Check out the online TTS 2024 Program

Time	Room	Session
07:00-08:00	22	22 07:00 Invited Symposia: “I’m Bringing Sexy Back”: Improving Fellows’ Interest in Solid Organ Transplantation Full Details Samira Farouk, United States “I’m Loving It”: How Do We Increase Exposure for Medical Students, Residents and Fellows Samira Farouk, United States “I’m Loving It”: How Do We Increase Exposure for Medical Students, Residents and Fellows Anjana Pillai, United States “What Goes Around, Comes Around”: How to Be a Successful Transplantation Mentor Anjana Pillai, United States “What Goes Around, Comes Around”: How to Be a Successful Transplantation Mentor Jon Kobashigawa, United States “Cry Me a River”: Making the Field of Transplantation More Attractive Jon Kobashigawa, United States “Cry Me a River”: Making the Field of Transplantation More Attractive
07:00-08:00	10	10 07:00 Invited Symposia: Consequences of Pregnancy on Alloimmunity Full Details Anita Chong, United States Implications of Pregnancy on Immunity Anita Chong, United States Implications of Pregnancy on Immunity Fadi Lakkis, United States Innate Allorecognition and Reproductive Success Fadi Lakkis, United States Innate Allorecognition and Reproductive Success Ina Stelzer, United States Immunological Consequences of Microchimerism in Pregnancy Ina Stelzer, United States Immunological Consequences of Microchimerism in Pregnancy
07:00-08:00	4	4 07:00 Invited Symposia: Biomarkers - Will We Ever Get Closer to Predicting Outcomes Full Details Jennifer Li, Australia Pan Organ Biomarkers Jennifer Li, Australia Pan Organ Biomarkers Marc Raynaud, France What Is the Next IBox? Marc Raynaud, France What Is the Next IBox? Miguel Fribourg, United States A Redox-based Approach for Monitoring T Cell Function in Transplant Miguel Fribourg, United States A Redox-based Approach for Monitoring T Cell Function in Transplant
07:00-08:00	153	153 07:00 Invited Symposia: Top Papers in Transplant Infectious Diseases Full Details Marcus Pereira, United States Top Papers in Viral Infections Marcus Pereira, United States Top Papers in Viral Infections Nicolas Mueller, Switzerland Top Papers in Bacterial Infections Nicolas Mueller, Switzerland Top Papers in Bacterial Infections C. Orla Morrissey, Australia Top Papers in Fungal Infections C. Orla Morrissey, Australia Top Papers in Fungal Infections
07:00-08:00	155	155 07:00 Invited Symposia: Innovative Tools in Transplant Education Full Details Sara Dong, United States Developing a Podcast Sara Dong, United States Developing a Podcast Jeremey Walker, United States Gamification as a Learning Tool Jeremey Walker, United States Gamification as a Learning Tool Candice Coghlan, Canada Tips & Tricks for Patient Webinars Candice Coghlan, Canada Tips & Tricks for Patient Webinars
07:00-08:00	20	20 07:00 Invited Symposia: Challenges in the Management of Lung Transplant Recipients Full Details Matthew Hartwig, United States Gastroesophageal Reflux and Management Post-lung Transplant Matthew Hartwig, United States Gastroesophageal Reflux and Management Post-lung Transplant Erika Lease, United States Difficult to Manage Post-lung Transplant Infections Erika Lease, United States Difficult to Manage Post-lung Transplant Infections Stephen Juvet, Canada Alphabet Soup of Rejection Including Biomarkers: ALAD, BLAD, CLAD Stephen Juvet, Canada Alphabet Soup of Rejection Including Biomarkers: ALAD, BLAD, CLAD
07:00-08:00	25	25 07:00 Invited Symposia: Mortality and Cardio-Kidney-Metabolic Complications in Kidney Transplantation: The State of Evidence and the Need for Outcome Trials Full Details Shaifali Sandal, Canada Cardiometabolic and Renal (CVRM) Pathways to Post-kidney Transplant Mortality Shaifali Sandal, Canada Cardiometabolic and Renal (CVRM) Pathways to Post-kidney Transplant Mortality David Vock, United States The Need For Trials - Novel Trial Endpoints David Vock, United States The Need For Trials - Novel Trial Endpoints Martina McGrath, United States SGLT2 Inhibitors in Kidney Transplantation Martina McGrath, United States SGLT2 Inhibitors in Kidney Transplantation
07:00-08:00	21	21 07:00 Invited Symposia: Culturally Safe Organ Donation Full Details gurch randhawa, United Kingdom Cultural / Religious Barriers to Deceased and Living Donation Among Immigrant Populations gurch randhawa, United Kingdom Cultural / Religious Barriers to Deceased and Living Donation Among Immigrant Populations Caroline Tait, Canada Living Donation in Indigenous Populations Around the Globe Caroline Tait, Canada Living Donation in Indigenous Populations Around the Globe Rudolf Garcia-Gallont, Guatemala Living Donation in Poor Populations Rudolf Garcia-Gallont, Guatemala Living Donation in Poor Populations Burnett Kelly, United States Living and Deceased Donation in African Americans Burnett Kelly, United States Living and Deceased Donation in African Americans
07:00-08:00	23	23 07:00 Invited Symposia: Best Practices for Transitioning Pediatric Recipients to Adult Transplant Programs Full Details Anne Loes van Staa, Netherlands Transition in Chronic Illness Anne Loes van Staa, Netherlands Transition in Chronic Illness Megan Kamath, United States Challenges and Opportunities for Improvement Megan Kamath, United States Challenges and Opportunities for Improvement Anne Dipchand, Canada Strategies for Transition Anne Dipchand, Canada Strategies for Transition
07:00-08:00	24	24 07:00 Invited Symposia: State-of-the-Art BK Virus Full Details Camille Kotton, United States Overview of the Updated BK Guidelines Camille Kotton, United States Overview of the Updated BK Guidelines David Wojciechowski, United States Novel Treatment Paradigms for BK Virus David Wojciechowski, United States Novel Treatment Paradigms for BK Virus Ilies Benotmane, France Modulating Immunosuppression to Manage BK Ilies Benotmane, France Modulating Immunosuppression to Manage BK
07:00-08:00	9	9 07:00 Invited Symposia: New Frontiers in VCA and Uterus Transplantation Full Details Paige Porrett, United States Mother and Child: Basic and Translational Research in Uterus Transplantation Paige Porrett, United States Mother and Child: Basic and Translational Research in Uterus Transplantation Fadi Issa, United Kingdom Spatial Transcriptomics and VCA Fadi Issa, United Kingdom Spatial Transcriptomics and VCA Jelena Janjic, United States Can Nanotechnology revolutionize VCA Jelena Janjic, United States Can Nanotechnology revolutionize VCA
07:00-08:00	12	12 07:00 Rapid Fire Oral Abstract Session: Insights from Transplant Science Full Details Scott Krummey, United States Dual CXCR3 and CD28 Blockade Synergistically Prolongs Graft Survival and Potently Restrains Effector CD8⁺ T Cells Scott Krummey, United States Dual CXCR3 and CD28 Blockade Synergistically Prolongs Graft Survival and Potently Restrains Effector CD8⁺ T Cells Ashley Haluck-Kangas, United States Graft-Derived Extracellular Vesicles Carry miRNAs That Promote Macrophage M1 Polarization in a Murine Allogeneic Heart Transplant Model Ashley Haluck-Kangas, United States Graft-Derived Extracellular Vesicles Carry miRNAs That Promote Macrophage M1 Polarization in a Murine Allogeneic Heart Transplant Model Olivia Fay, United States Cytomegalovirus-Infected Dendritic Cells Demonstrate Dysregulated Insulin-Like Growth Factor Signaling Associated with Loss of T Cell Anergy Olivia Fay, United States Cytomegalovirus-Infected Dendritic Cells Demonstrate Dysregulated Insulin-Like Growth Factor Signaling Associated with Loss of T Cell Anergy Jasmine Shwetar, United States Heterogeneous B Cell Subsets Clonally Expand in Human Lymph Nodes under Immunosuppression Jasmine Shwetar, United States Heterogeneous B Cell Subsets Clonally Expand in Human Lymph Nodes under Immunosuppression Kohei Kinoshita, United States Graft Survival and Rejection Risk with TNX-1500 as Monotherapy or in Combination with Conventional IS Agents in Nonhuman Primate Heart Transplants Kohei Kinoshita, United States Graft Survival and Rejection Risk with TNX-1500 as Monotherapy or in Combination with Conventional IS Agents in Nonhuman Primate Heart Transplants James Keiler, United States Adjuvant IL15 Blockade Significantly Improves Survival When Combined with a Costimulation-Based Immunosuppression Protocol of Pig-to-Nonhuman Primate Renal Xenotransplantation James Keiler, United States Adjuvant IL15 Blockade Significantly Improves Survival When Combined with a Costimulation-Based Immunosuppression Protocol of Pig-to-Nonhuman Primate Renal Xenotransplantation James Keiler, United States Targeting CD11b - An Alternative Binding Site of CD154 - Increases the Prevalence of Exhausted TEMRA CD8 T Cells in a Nonhuman Primate Model of Renal Allotransplantation James Keiler, United States Targeting CD11b - An Alternative Binding Site of CD154 - Increases the Prevalence of Exhausted TEMRA CD8 T Cells in a Nonhuman Primate Model of Renal Allotransplantation Kohei Kinoshita, United States Dual Blockade of CD154 and CD28 Co-Stimulation Pathways Mitigates Pathogenic Allo-Immunity and Enhances Survival in Cynomolgus Cardiac Transplantation Kohei Kinoshita, United States Dual Blockade of CD154 and CD28 Co-Stimulation Pathways Mitigates Pathogenic Allo-Immunity and Enhances Survival in Cynomolgus Cardiac Transplantation
07:00-08:00	8	8 07:00 Rapid Fire Oral Abstract Session: Deceased Donor Kidney Access to Waitlist/Transplant Outcomes Full Details Amy Waterman, United States Identifying Quality Improvement Opportunities to Increase Early Transplant Preparation and Pursuit of Transplant Amy Waterman, United States Identifying Quality Improvement Opportunities to Increase Early Transplant Preparation and Pursuit of Transplant Sobhana Thangaraju, Singapore National Trends of Sex Disparity over 5 Decades of Living Donor Kidney Transplantation in Singapore Sobhana Thangaraju, Singapore National Trends of Sex Disparity over 5 Decades of Living Donor Kidney Transplantation in Singapore Fawaz Al Ammary, United States Association Between California Kidney Transplant Waitlist and Living Donor Kidney Transplantation Fawaz Al Ammary, United States Association Between California Kidney Transplant Waitlist and Living Donor Kidney Transplantation Anil Paramesh, United States From Bias to Balance: The Role of Race-Neutral eGFR in African American Transplant Equity Anil Paramesh, United States From Bias to Balance: The Role of Race-Neutral eGFR in African American Transplant Equity Tennille Vitagliano, Australia Intersectional Disadvantage and It's Effect on Living Donor Kidney Transplant Access in Australia: A National Cohort Study (2006-2023) Tennille Vitagliano, Australia Intersectional Disadvantage and It's Effect on Living Donor Kidney Transplant Access in Australia: A National Cohort Study (2006-2023) Lung-Yi Lee, United States Disparities in Kidney Transplantation Access and Outcomes Among Native Hawaiians and Pacific Islanders in the United States Lung-Yi Lee, United States Disparities in Kidney Transplantation Access and Outcomes Among Native Hawaiians and Pacific Islanders in the United States John Holland, United Kingdom Comprehensive Geriatric Assessment (CGA) and Optimisation Services Prior to Kidney Transplantation in Older Potential Recipients: Results from the First UK-Wide Transplant Centre and Renal Unit Survey Study John Holland, United Kingdom Comprehensive Geriatric Assessment (CGA) and Optimisation Services Prior to Kidney Transplantation in Older Potential Recipients: Results from the First UK-Wide Transplant Centre and Renal Unit Survey Study Stuart Knechtle, United States Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation: Preliminary Results of the ADAPT Trial Stuart Knechtle, United States Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation: Preliminary Results of the ADAPT Trial
07:00-08:00	11	11 07:00 Invited Symposia: Why Are Islet Cell Transplants Failing in the US and Thriving in the Rest of the World? Full Details Piotr Witkowski, United States Challenges in the US Leading To the Demise of Islet Allotx Piotr Witkowski, United States Challenges in the US Leading To the Demise of Islet Allotx Trevor Reichman, Canada Pancreatic Islet Transplant: A Viable Alternative to Pancreas Transplantation Trevor Reichman, Canada Pancreatic Islet Transplant: A Viable Alternative to Pancreas Transplantation
07:00-08:00	154	154 07:00 Late-Breaking Oral Abstract: Non Immunological Outcomes Full Details Anthony Langone, United States Cognitive Outcomes and Quality of Life in Stable Renal Transplant Patients Switched from Twice-Daily Tacrolimus to Envarsus XR^TM Anthony Langone, United States Cognitive Outcomes and Quality of Life in Stable Renal Transplant Patients Switched from Twice-Daily Tacrolimus to Envarsus XR^TM BEATRIZ RODRIGUEZ-CUBILLO, Spain Impact of a Multidisciplinary, Holistic Clinic on Kidney-Transplant Recipients with Complex Needs: Twelve-Month Prospective Evaluation BEATRIZ RODRIGUEZ-CUBILLO, Spain Impact of a Multidisciplinary, Holistic Clinic on Kidney-Transplant Recipients with Complex Needs: Twelve-Month Prospective Evaluation BEATRIZ RODRIGUEZ-CUBILLO, Spain Clinical and Symptom Profile of Kidney Transplant Recipients Flagged by the NECPAL Tool: Cross-Sectional Analysis from a Multidisciplinary Clinic BEATRIZ RODRIGUEZ-CUBILLO, Spain Clinical and Symptom Profile of Kidney Transplant Recipients Flagged by the NECPAL Tool: Cross-Sectional Analysis from a Multidisciplinary Clinic Elias David Neto, Brazil The Effect of Adding Dapagliflozin on Chronic Allograft Dysfunction. A Prospective, Randomized, Double-Blind, Placebo-Control Trial Elias David Neto, Brazil The Effect of Adding Dapagliflozin on Chronic Allograft Dysfunction. A Prospective, Randomized, Double-Blind, Placebo-Control Trial Hee Jung Jeon, Korea Association of Post-Transplant Apolipoprotein A-1 Levels with Cardiovascular Events and Graft Loss in Kidney Transplant Recipients: Results from the KOTRY Study Hee Jung Jeon, Korea Association of Post-Transplant Apolipoprotein A-1 Levels with Cardiovascular Events and Graft Loss in Kidney Transplant Recipients: Results from the KOTRY Study
08:15-09:30	20	20 08:15 Invited Symposia: Psychosocial Issues in Living Donation Full Details AnnMarie Liapakis, United States The Overwhelmed Donor AnnMarie Liapakis, United States The Overwhelmed Donor Peter Reese, United States Care of the Denied Donor Peter Reese, United States Care of the Denied Donor Martina McGrath, United States The Psychosocial Risks and Benefits of Living Donation Martina McGrath, United States The Psychosocial Risks and Benefits of Living Donation Filza Hussain, United States Substance Use in Living Donors Filza Hussain, United States Substance Use in Living Donors
08:15-09:30	8	8 08:15 Invited Symposia: Challenging Cases World Edition: Transplant ID Experiences Across the Globe Full Details Marian Michaels, United States Panelist Marian Michaels, United States Panelist Thuan Tong Tan, Singapore Panelist Thuan Tong Tan, Singapore Panelist Sara Belga, Canada Panelist Sara Belga, Canada Panelist Ligia Pierrotti, Brazil Panelists Ligia Pierrotti, Brazil Panelists Ajit Limaye, United States Panelists Ajit Limaye, United States Panelists
08:15-09:30	21	21 08:15 Invited Symposia: Advanced Practice Providers on the Cutting Edge: Expanding Roles in Surgery and Transplant Research Full Details Erin Kinsella, United States APP-Led Robotics: APPs in Robotic and Minimally Invasive Donor Surgery Erin Kinsella, United States APP-Led Robotics: APPs in Robotic and Minimally Invasive Donor Surgery Carlee Komoroski, United States Lifeline Logistics: APPs on the Frontlines of Organ Procurement Carlee Komoroski, United States Lifeline Logistics: APPs on the Frontlines of Organ Procurement Kelly Cederquist, United States Into the Future: APPs in Research Kelly Cederquist, United States Into the Future: APPs in Research Georgeine Smith, United States Guardians of Viability: APPs in Organ Perfusion and Preservation Georgeine Smith, United States Guardians of Viability: APPs in Organ Perfusion and Preservation
08:15-09:30	12	12 08:15 Invited Symposia: Pediatric Access to Transplantation Full Details Jennifer Vittorio, United States Overview of Global Pediatric Access to Transplantation Jennifer Vittorio, United States Overview of Global Pediatric Access to Transplantation Julie Ingelfinger, United States Dare to Dream - A World Where Every Child in Need Receives a Transplant! Julie Ingelfinger, United States Dare to Dream - A World Where Every Child in Need Receives a Transplant! Sajid Sultan, Pakistan Role of Philanthropy Sajid Sultan, Pakistan Role of Philanthropy Emily Perito, United States How to Increase Deceased Donor Organ Availability for Pediatric Recipients Emily Perito, United States How to Increase Deceased Donor Organ Availability for Pediatric Recipients
08:15-09:30	155	155 08:15 Invited Symposia: Innovation in Organ Allocation Full Details James Lan, Canada Eplet Matching - Is It Feasible and Equitable? James Lan, Canada Eplet Matching - Is It Feasible and Equitable? Deirdre Sawinski, United States Preemptive Transplantation Deirdre Sawinski, United States Preemptive Transplantation Betsy Verna, United States Moving Away From Transplanting the Sickest Patients in Liver Transplantation Betsy Verna, United States Moving Away From Transplanting the Sickest Patients in Liver Transplantation Jon Snyder, United States Continuous Distribution Jon Snyder, United States Continuous Distribution Elizabeth Pomfret, United States Longevity Matching Revisited Elizabeth Pomfret, United States Longevity Matching Revisited
08:15-09:30	10	10 08:15 Invited Symposia: Transplantation in the Context of Migration and Refugees: An Update of the DICG and TTS Ethics Committee Workshop TTS 2022 Full Details Toby Coates, Australia Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Australia / Refugees From SE Asia, Pacific Islands) Toby Coates, Australia Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Australia / Refugees From SE Asia, Pacific Islands) Jolanta Malyszko, Poland Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Poland / Refugees-Migrants From Ukraine) Jolanta Malyszko, Poland Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Poland / Refugees-Migrants From Ukraine) Alejandro Murcia, Colombia Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Colombia / Refugees-Migrants From Venezuela) Alejandro Murcia, Colombia Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Colombia / Refugees-Migrants From Venezuela) Peter Stock, United States Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (USA / Refugees-Migrants Non US Citizens to USA) Peter Stock, United States Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (USA / Refugees-Migrants Non US Citizens to USA) Frederike Ambagtsheer, Netherlands Ethical and Legal Challenges Impacting Refugees and Migrants With ESRD - The Need for International Attention Frederike Ambagtsheer, Netherlands Ethical and Legal Challenges Impacting Refugees and Migrants With ESRD - The Need for International Attention Rumeyza Kazancioglu, Turkey Access to Dialysis/Transplantation for Syrian Refugees in Türkiye Rumeyza Kazancioglu, Turkey Access to Dialysis/Transplantation for Syrian Refugees in Türkiye Mekdim Tadesse Siyoum, Ethiopia Transplantation in Ethiopia - The Impact of Internal Conflict Mekdim Tadesse Siyoum, Ethiopia Transplantation in Ethiopia - The Impact of Internal Conflict
08:15-09:30	154	154 08:15 Invited Symposia: Donor Follow Up – How Can We Do Better? Full Details Ngan Lam, Canada The Global Status of Post-Donation Follow-Up Ngan Lam, Canada The Global Status of Post-Donation Follow-Up Ajay Israni, United States Efforts to Establish Follow Up in the US Ajay Israni, United States Efforts to Establish Follow Up in the US Sunita Singh, Canada What Do Donors Want? Sunita Singh, Canada What Do Donors Want? Emilio Poggio, United States Engaging Donors in Health Maintenance Post Donation Emilio Poggio, United States Engaging Donors in Health Maintenance Post Donation Hajeong Lee, Korea Living Donor Registry: The South Korean Experience Hajeong Lee, Korea Living Donor Registry: The South Korean Experience
08:15-09:30	23	23 08:15 Invited Symposia: Quality and Value in Organ Donation and Transplantation Full Details Rutger Ploeg, United Kingdom Quality in Organ Donation Services Rutger Ploeg, United Kingdom Quality in Organ Donation Services Greg Knoll, Canada Quality in Kidney Transplantation Greg Knoll, Canada Quality in Kidney Transplantation Brooke Iarkowski, United States Quality From the Donor's Perspective: A Past Living Donor's Perspective Brooke Iarkowski, United States Quality From the Donor's Perspective: A Past Living Donor's Perspective Alexandra Glazier, United States You Know It When You See It - The Elusive Concepts of Quality and Value in Healthcare Alexandra Glazier, United States You Know It When You See It - The Elusive Concepts of Quality and Value in Healthcare Kevin Longino, United States Measures of What Matters to Patients Kevin Longino, United States Measures of What Matters to Patients
08:15-09:30	153	153 08:15 Invited Symposia: Ethics and Legal Considerations in Deceased Donation Full Details Maryl Johnson, United States Deceased Donor Intervention Research Maryl Johnson, United States Deceased Donor Intervention Research Sanjay Nagral, India Donor Rewards and Recognition: International Perspective Sanjay Nagral, India Donor Rewards and Recognition: International Perspective Kim Wiebe, Canada Deceased Donation After Medical Assistance in Dying Kim Wiebe, Canada Deceased Donation After Medical Assistance in Dying Anji Wall, United States Ethics of Normothermic Regional Perfusion Anji Wall, United States Ethics of Normothermic Regional Perfusion
08:15-09:30	24	24 08:15 Invited Symposia: From "Good Enough" to "Great": Addressing Barriers to Improving Immunosuppression Full Details Nithya Santhana Krishnan, United Kingdom The (Unspoken) Risks of Over-Immunosuppression Nithya Santhana Krishnan, United Kingdom The (Unspoken) Risks of Over-Immunosuppression Stefan Schneeberger, Austria Regulatory Pathways and Barriers to Innovation: Lessons from the EMA Stefan Schneeberger, Austria Regulatory Pathways and Barriers to Innovation: Lessons from the EMA Ulf Meier-Kriesche, United States Industry Partners: Friends or Foes? Ulf Meier-Kriesche, United States Industry Partners: Friends or Foes? Dirk Kuypers, Belgium Can Technology and Therapeutic Monitoring Strategies Improve the Gap? Dirk Kuypers, Belgium Can Technology and Therapeutic Monitoring Strategies Improve the Gap? Michael Collins, Australia Structuring Trials of Novel Agents: Risks and Opportunities Michael Collins, Australia Structuring Trials of Novel Agents: Risks and Opportunities
08:15-09:30	4	4 08:15 Invited Symposia: Innovations in Organ Preservation and Perfusion Strategies Full Details Peter Abt, United States The Evidence for in Situ Versus Ex Situ Perfusion of DCD Donor Organs Peter Abt, United States The Evidence for in Situ Versus Ex Situ Perfusion of DCD Donor Organs David Axelrod, United States Economic Considerations of Implementing Perfusion Technology: Can We Afford It? David Axelrod, United States Economic Considerations of Implementing Perfusion Technology: Can We Afford It? Erik Finger, United States Cryopreservation, Vitrification, and Nano-Rewarming: The Next Innovation in Organ Erik Finger, United States Cryopreservation, Vitrification, and Nano-Rewarming: The Next Innovation in Organ ROBERT Porte, Netherlands Advancements in Combined Hypothermic and Normothermic Machine Perfusion: Controlled Oxygenated Rewarming ROBERT Porte, Netherlands Advancements in Combined Hypothermic and Normothermic Machine Perfusion: Controlled Oxygenated Rewarming
08:15-09:30	22	22 08:15 Invited Symposia: Harnessing Social Media for Good Full Details Juliet Emamaullee, United States Creating a Social Profile to Advance Your Science: Pearls and Pitfalls Juliet Emamaullee, United States Creating a Social Profile to Advance Your Science: Pearls and Pitfalls SUNIL SHROFF, India Using Social Media to Increase Organ Donation Awareness and Support SUNIL SHROFF, India Using Social Media to Increase Organ Donation Awareness and Support Macey Levan, United States Using Social Media to Find a Donor Macey Levan, United States Using Social Media to Find a Donor Richard Hasz, United States Spreading the Gospel of Transplant to the Public Richard Hasz, United States Spreading the Gospel of Transplant to the Public
08:15-09:30	9	9 08:15 Oral Abstract: VCA Full Details YINAN GUO, United States Myd88-Areg Axis in Regulating Host Responses to Vascularized Composite Allotransplantation YINAN GUO, United States Myd88-Areg Axis in Regulating Host Responses to Vascularized Composite Allotransplantation Bruce Gelb, United States Post-Transplant Malignancy Following Vascularized Composite Allotransplantation Bruce Gelb, United States Post-Transplant Malignancy Following Vascularized Composite Allotransplantation Jelena Janjic, United States A First-in-Class Imaging Capable Acellular Oxygen Nanocarrier Perfusate for Extended Machine Preservation of Organs Jelena Janjic, United States A First-in-Class Imaging Capable Acellular Oxygen Nanocarrier Perfusate for Extended Machine Preservation of Organs Paige Porrett, United States Spectrum of Pregnancy Complications Induced by Tacrolimus Paige Porrett, United States Spectrum of Pregnancy Complications Induced by Tacrolimus Daniel Brennan, United States Donor-Derived Cell-Free DNA (dd-cfDNA) in Vascularized Composite Allograft Recipients Daniel Brennan, United States Donor-Derived Cell-Free DNA (dd-cfDNA) in Vascularized Composite Allograft Recipients Elizabeth Stearns, United States Optimizing VCA Donors: Transplant Center Perspective Elizabeth Stearns, United States Optimizing VCA Donors: Transplant Center Perspective William Crisler, United States Sentinel Flaps Reflect Inflammation and Rejection in Human Face Allografts William Crisler, United States Sentinel Flaps Reflect Inflammation and Rejection in Human Face Allografts Nima Nassiri, United States First-In-Human Bladder Transplant Nima Nassiri, United States First-In-Human Bladder Transplant
08:15-09:30	25	25 08:15 Invited Symposia: Costimulation - from Biology to Clinical Trials Full Details David Hildeman, United States Single Cell Analysis of Rejection under Costimulation Blockade David Hildeman, United States Single Cell Analysis of Rejection under Costimulation Blockade Mandy Ford, United States Fgl2/Fcgr2b - The New Kid on the Block Mandy Ford, United States Fgl2/Fcgr2b - The New Kid on the Block Allan Kirk, United States Blocking CD40/CD40L in Allo and Xenotransplantation Allan Kirk, United States Blocking CD40/CD40L in Allo and Xenotransplantation Gilles Blancho, France FIRsT - Anti-CD28 Fabs in humans (Phase 1/2 study) Gilles Blancho, France FIRsT - Anti-CD28 Fabs in humans (Phase 1/2 study)
08:15-09:30	11	11 08:15 Late-Breaking Oral Abstract: Liver Transplantation: New Techniques, Immunosuppression Strategies and Patient Outcomes Full Details Kishore Iyer, United States The Bypass Paradox - Frequency and Impact of UNOS Bypass Code 850 on ‘Out of Sequence’ liver Allocation Kishore Iyer, United States The Bypass Paradox - Frequency and Impact of UNOS Bypass Code 850 on ‘Out of Sequence’ liver Allocation Erin Duggan, United States A Stepwise Institutional Progression to Total Robotic Liver Transplantation: Technical Refinements into a Simpler and Reproducible Technique Across Eight Cases Erin Duggan, United States A Stepwise Institutional Progression to Total Robotic Liver Transplantation: Technical Refinements into a Simpler and Reproducible Technique Across Eight Cases Pranit Chotai Trends and Recipient Outcomes in Liver Transplants from Hepatitis C Donors: A National Analysis by Donor Age Pranit Chotai Trends and Recipient Outcomes in Liver Transplants from Hepatitis C Donors: A National Analysis by Donor Age Yuzuru Sambommatsu, United States Total Robotic Living Donor Liver Transplantation: First North American Case Yuzuru Sambommatsu, United States Total Robotic Living Donor Liver Transplantation: First North American Case Marco Maria Pascale, Italy Immunomodulation through Hypothermic Oxygenated Perfusion in Liver Transplantation: Biomarker Analysis in Peripheral Blood Marco Maria Pascale, Italy Immunomodulation through Hypothermic Oxygenated Perfusion in Liver Transplantation: Biomarker Analysis in Peripheral Blood Ilya Kantsedikas, United Kingdom Living Liver Donor Intra-operative Analgesia and Day 1 Pain - Insights from the International LDLT Registry Ilya Kantsedikas, United Kingdom Living Liver Donor Intra-operative Analgesia and Day 1 Pain - Insights from the International LDLT Registry Michelle Callegari, United States Health-Related Quality of Life Improves Rapidly after Liver Transplantation - Findings from the PRO-LT Study Michelle Callegari, United States Health-Related Quality of Life Improves Rapidly after Liver Transplantation - Findings from the PRO-LT Study
10:00-10:30	Plenary	Plenary 10:00 Stem Cell Derived Beta Cell Clusters and Successful Allotransplantation - Hongkui Deng Full Details Hongkui Deng, People's Republic of China Stem Cell Derived Beta Cell Clusters and Successful Allotransplantation Hongkui Deng, People's Republic of China Stem Cell Derived Beta Cell Clusters and Successful Allotransplantation
10:30-11:30	Plenary	Plenary 10:30 Plenary: Plenary Abstracts 3 Full Details Dirk Kuypers, Belgium Integrated Model-Informed Precision Dosing (MIPD) of Tacrolimus in Organ Transplantation Dirk Kuypers, Belgium Integrated Model-Informed Precision Dosing (MIPD) of Tacrolimus in Organ Transplantation Khodor Abou-Daya, United States Ly6-C^hiCD56⁺ Stem-Like Monocytes Propagate Specific Innate Immune Memory Khodor Abou-Daya, United States Ly6-C^hiCD56⁺ Stem-Like Monocytes Propagate Specific Innate Immune Memory Fei-Man Hsu, United States First-Year Post-Transplant Respiratory DNA Methylation Profile Predicts Chronic Lung Allograft Dysfunction Fei-Man Hsu, United States First-Year Post-Transplant Respiratory DNA Methylation Profile Predicts Chronic Lung Allograft Dysfunction Thiago J. Borges, United States High-Resolution Profiling of Immune Responses Following Gene-Edited Pig Kidney Xenotransplantation Thiago J. Borges, United States High-Resolution Profiling of Immune Responses Following Gene-Edited Pig Kidney Xenotransplantation
11:30-12:45	Plenary	Plenary 11:30 Presidential Addresses: TTS Presidential Address & Society Awards Full Details Peter Stock, United States Introduction of John Fung Peter Stock, United States Introduction of John Fung John Fung, United States Presidential Address John Fung, United States Presidential Address Maria Matamoros, Costa Rica DICG Updates Maria Matamoros, Costa Rica DICG Updates John Fung, United States Introduction of TTS Journals EiC John Fung, United States Introduction of TTS Journals EiC Stefan Tullius, United States TTS Journals - EiC Highlghts Stefan Tullius, United States TTS Journals - EiC Highlghts John Fung, United States Brent & Monaco Awards John Fung, United States Brent & Monaco Awards John Fung, United States Introduction of Sanjeev Kanoria Awards Program John Fung, United States Introduction of Sanjeev Kanoria Awards Program Nadey Hakim, United Kingdom Introduction of Sanjeev Kanoria Nadey Hakim, United Kingdom Introduction of Sanjeev Kanoria Sanjeev Kanoria, United Kingdom Speaker Sanjeev Kanoria, United Kingdom Speaker John Fung, United States Closing & invitation to TTS 2026 John Fung, United States Closing & invitation to TTS 2026
12:15-15:30	154	154 12:15 Invited Symposia: Global Perspectives on Genetic Insights for Optimizing Transplant Success Full Details Madhav Menon, United States Non-HLA Genetic Factors in Recipient and Donor Compatibility Madhav Menon, United States Non-HLA Genetic Factors in Recipient and Donor Compatibility Dirk Kuypers, Belgium Complex Genetic Conditions, Pharmacogenomics and Polygenic Risk Scores in Kidney Transplantation: A Global Approach Dirk Kuypers, Belgium Complex Genetic Conditions, Pharmacogenomics and Polygenic Risk Scores in Kidney Transplantation: A Global Approach Yasar Caliskan, United States Clinical Use of Genetic Testing for Monogenic Diseases in Transplant Recipients: Regional Applications Yasar Caliskan, United States Clinical Use of Genetic Testing for Monogenic Diseases in Transplant Recipients: Regional Applications Francesca Zanoni, Italy Clinical Use of Genetic Testing for Monogenic Diseases in Transplant Recipients: Regional Applications Francesca Zanoni, Italy Clinical Use of Genetic Testing for Monogenic Diseases in Transplant Recipients: Regional Applications
12:15-15:30	25	25 12:15 Invited Symposia: Xenotransplantation - Clinical Achievements and Next Steps Full Details Wayne Hawthorne, Australia History and Current Status of the Field Wayne Hawthorne, Australia History and Current Status of the Field Winfred Williams, United States The Right Patient Winfred Williams, United States The Right Patient Alfred Tector, United States The Right Pig Alfred Tector, United States The Right Pig Alfred Tector, United States The Right Immunosuppression Alfred Tector, United States The Right Immunosuppression
12:15-15:30	23	23 12:15 Invited Symposia: Novel Diagnostics in Transplant Infectious Diseases. Some Hope or Just Nope? Full Details Kimberly Hanson, United States Microbial cfDNA: Ready for Universal Use (CON) Kimberly Hanson, United States Microbial cfDNA: Ready for Universal Use (CON) Monica Fung, United States Microbial cfDNA: Ready for Universal Use (PRO) Monica Fung, United States Microbial cfDNA: Ready for Universal Use (PRO) John W. Baddley, United States Does Galactomannan Change Your Management? (PRO) John W. Baddley, United States Does Galactomannan Change Your Management? (PRO) Sophia Koo, United States Does Galactomannan Change Your Management? (CON) Sophia Koo, United States Does Galactomannan Change Your Management? (CON)
12:15-15:30	11	11 12:15 Invited Symposia: Navigating the Future: Implementation of Patient Navigation Strategies in Organ Transplant Across the Globe Full Details Nicole Scholes-Robertson, Australia Rural & Remote Access to Healthcare for Patients With Chronic Kidney Disease Nicole Scholes-Robertson, Australia Rural & Remote Access to Healthcare for Patients With Chronic Kidney Disease Tanjala Purnell, United States Equity in Access to Kidney Transplantation Tanjala Purnell, United States Equity in Access to Kidney Transplantation WTC 2025, Singapore Panel Discussion WTC 2025, Singapore Panel Discussion
12:15-15:30	10	10 12:15 Invited Symposia: Pregnancy in Transplant Recipients: From Preconception to Birth Full Details Silvi Shah, United States Preconception Counseling Silvi Shah, United States Preconception Counseling Nicole Alvey, United States Medication Safety During Pregnancy and Breastfeeding Nicole Alvey, United States Medication Safety During Pregnancy and Breastfeeding Monika Sarkar, United States Contraception Monika Sarkar, United States Contraception Margriet de Jong, Netherlands Lessons Learned From Pregnancy Registries Worldwide Margriet de Jong, Netherlands Lessons Learned From Pregnancy Registries Worldwide
12:15-15:30	155	155 12:15 Invited Symposia: Addressing Disparities in Access to Transplantation Full Details Lisa McElroy, United States Social Determinants of Health - Measures and Interventions Lisa McElroy, United States Social Determinants of Health - Measures and Interventions Sixto Giusti, United States Undocumented Persons Sixto Giusti, United States Undocumented Persons Elizabeth Hendren, Canada Gender Disparities - Global Perspective Elizabeth Hendren, Canada Gender Disparities - Global Perspective Teri Browne, United States Community Engagement Strategies Teri Browne, United States Community Engagement Strategies Leigh Anne Dageforde, United States Health Literacy Leigh Anne Dageforde, United States Health Literacy
12:15-15:30	8	8 12:15 Invited Symposia: Wait-List Access and Management Full Details Jesse Schold, United States Mandatory Referral to the Wait-List Jesse Schold, United States Mandatory Referral to the Wait-List Tracey Ying, Australia Screening for CAD Tracey Ying, Australia Screening for CAD Germaine Wong, Australia Waitlisting the Patient with Cancer Germaine Wong, Australia Waitlisting the Patient with Cancer Joel Adler, United States Patient Representation on Wl Selection Committees Joel Adler, United States Patient Representation on Wl Selection Committees Adnan Sharif, United Kingdom Should There Be a Standard Approach to Removing Patients from the Waiting List Adnan Sharif, United Kingdom Should There Be a Standard Approach to Removing Patients from the Waiting List
12:15-15:30	22	22 12:15 Invited Symposia: Non-HCC Liver Malignancy and Transplantation: Evolving Patient Selection Criteria, Graft Preservation Methods, and Post-transplant Outcomes Full Details Dong-Sik Kim, Korea Unresectable Colorectal Liver Metastases: Updates in Recipient Selection, Surgical Techniques and Post-transplant Outcomes Dong-Sik Kim, Korea Unresectable Colorectal Liver Metastases: Updates in Recipient Selection, Surgical Techniques and Post-transplant Outcomes Keri Lunsford, United States Advancements in Transplant Oncology for Cholangiocarcinoma Keri Lunsford, United States Advancements in Transplant Oncology for Cholangiocarcinoma Laia Aceitunosierra, Canada Biomarkers Predictive of Recurrent Liver Tumors Laia Aceitunosierra, Canada Biomarkers Predictive of Recurrent Liver Tumors Andrea Schlegel, United States Impact of Donor Characteristics and Graft Preservation Methods on Post-transplant Outcomes Andrea Schlegel, United States Impact of Donor Characteristics and Graft Preservation Methods on Post-transplant Outcomes
12:15-15:30	4	4 12:15 Invited Symposia: Artificial Intelligence in Transplantation: From Theory to Practice Full Details Jean Yang, Australia Multi-Omics Integration in Transplantation Jean Yang, Australia Multi-Omics Integration in Transplantation Alexandre Loupy, France Integrating Artificial Intelligence into Clinical Decision Making: Promise of a Virtual Biopsy Alexandre Loupy, France Integrating Artificial Intelligence into Clinical Decision Making: Promise of a Virtual Biopsy Mohammed Akhtar, United States AI: Present and Future: Potential for Solid Organ Transplantation Mohammed Akhtar, United States AI: Present and Future: Potential for Solid Organ Transplantation Nikki Marks, Canada Role of Generative AI in Transplant Medicine Nikki Marks, Canada Role of Generative AI in Transplant Medicine
12:15-15:15	9	9 12:15 Invited Symposia: Updates from STAR Full Details Chris Wiebe, Canada Updates in the Analytic and Clinical Validity of Non-HLA DSA Testing Chris Wiebe, Canada Updates in the Analytic and Clinical Validity of Non-HLA DSA Testing Marlena Habal, United States Practical Use of Titers to Measure HLA Antibody Reduction Marlena Habal, United States Practical Use of Titers to Measure HLA Antibody Reduction Kelley Hitchman, United States Donor Derived Cell Free DNA: The Path to Clinical Utility Kelley Hitchman, United States Donor Derived Cell Free DNA: The Path to Clinical Utility
12:15-15:15	24	24 12:15 Invited Symposia: 70th Anniversary of the First Successful LD Kidney Transplant Full Details Lloyd Ratner, United States Surgical Advances Over Time Lloyd Ratner, United States Surgical Advances Over Time Robert Montgomery, United States The Incompatibility Challenge : From Identical Twins to Kidney Paired Donation Robert Montgomery, United States The Incompatibility Challenge : From Identical Twins to Kidney Paired Donation Arthur Matas, United States Evolution of the Understanding of Donor Risk Arthur Matas, United States Evolution of the Understanding of Donor Risk J. Harold Helderman, United States Remembering the First Kidney Transplant J. Harold Helderman, United States Remembering the First Kidney Transplant Denice Lombard, United States The Longest Surviving Living Donor Transplant Recipient Denice Lombard, United States The Longest Surviving Living Donor Transplant Recipient Jamil Azzi, United States The First Transplant in Pictures Jamil Azzi, United States The First Transplant in Pictures
12:15-15:15	20	20 12:15 Invited Symposia: New Drugs in Pediatric Transplantation Full Details Marc Foca, United States Antivirals Marc Foca, United States Antivirals Carissa Baker-Smith, United States Glp-1 Carissa Baker-Smith, United States Glp-1 Rouba Garro, United States Sglt-2 Rouba Garro, United States Sglt-2
12:15-15:30	21	21 12:15 Oral Abstract: Global Trends in Donor-Derived Infections Full Details Helen Te, United States Donor-Derived Hepatitis B Virus (HBV) Infection in Solid Organ Transplant (SOT) Recipients: Report from the Organ Procurement & Transplantation Network Ad Hoc Disease Transmission Advisory Committee (OPTN DTAC) Helen Te, United States Donor-Derived Hepatitis B Virus (HBV) Infection in Solid Organ Transplant (SOT) Recipients: Report from the Organ Procurement & Transplantation Network Ad Hoc Disease Transmission Advisory Committee (OPTN DTAC) Ines Ushiro-Lumb, United Kingdom Lessons from a Newly Implemented Organ Donor Screening for Human Herpes Virus Type 8 in the UK Ines Ushiro-Lumb, United Kingdom Lessons from a Newly Implemented Organ Donor Screening for Human Herpes Virus Type 8 in the UK José Pestana, Brazil Impact of Dengue Outbreak on Solid Organ Transplant Programs in an Endemic Region: Devising and Implementation of Risk Mitigation Strategies José Pestana, Brazil Impact of Dengue Outbreak on Solid Organ Transplant Programs in an Endemic Region: Devising and Implementation of Risk Mitigation Strategies Dzhuliyana Handarova, United States Trends in Deceased Donor 2020 Public Health Service Guideline Risk Criteria Dzhuliyana Handarova, United States Trends in Deceased Donor 2020 Public Health Service Guideline Risk Criteria Klaus Böhler, Germany Donor-Derived Infections in Deceased Donor Organ Transplantation in Germany from 2016-2024 Klaus Böhler, Germany Donor-Derived Infections in Deceased Donor Organ Transplantation in Germany from 2016-2024 Stephanie Pouch, United States Donor-Derived Transmissions 2023: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC) Stephanie Pouch, United States Donor-Derived Transmissions 2023: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC) Olivia Smibert, Australia Burden of Infectious Diseases in Potential Organ Donors in Victoria, a Retrospective Audit of All Potential Organ Donors Between 2014-2024 Olivia Smibert, Australia Burden of Infectious Diseases in Potential Organ Donors in Victoria, a Retrospective Audit of All Potential Organ Donors Between 2014-2024 Oscar Fernandez Garcia, Canada Trends in Deceased Organ Donor Risk Factors for Bloodborne Infections. A Single-Centre Retrospective Study Oscar Fernandez Garcia, Canada Trends in Deceased Organ Donor Risk Factors for Bloodborne Infections. A Single-Centre Retrospective Study
12:15-15:30	153	153 12:15 Oral Abstract: Deceased Donor Kidney Allocation 2 Full Details David Walls, United States Out-of-Sequence Kidney Allocation: Identifying a Subgroup with Superior Outcomes David Walls, United States Out-of-Sequence Kidney Allocation: Identifying a Subgroup with Superior Outcomes David Walls, United States Out-of-Sequence Allocation Allows Increased Utilization of Kidneys While Providing Equivalent Outcomes to Standard Allocation Kidney Transplants David Walls, United States Out-of-Sequence Allocation Allows Increased Utilization of Kidneys While Providing Equivalent Outcomes to Standard Allocation Kidney Transplants Keighly Bradbrook, United States Deceased Donor Kidneys Allocated out of Sequence Differ from Kidneys Allocated in Sequence - Do Outcomes Differ? Keighly Bradbrook, United States Deceased Donor Kidneys Allocated out of Sequence Differ from Kidneys Allocated in Sequence - Do Outcomes Differ? Douglas Keith, United States The Current Iteration of Zero HLA Mismatch Priority in KAS is Highly Biased Against Minorities, Shunts Kidneys Away from Blood Type O Recipients, and Has a Marginal Impact on Graft and Patient Outcomes Douglas Keith, United States The Current Iteration of Zero HLA Mismatch Priority in KAS is Highly Biased Against Minorities, Shunts Kidneys Away from Blood Type O Recipients, and Has a Marginal Impact on Graft and Patient Outcomes Keith McCullough, United States HLA Class I Amino Acid Mismatches That Distinguish Divergent HLA-A Allele Lineages Confer Incremental Risk of Kidney Allograft Failure Independent of Class II Mismatches Keith McCullough, United States HLA Class I Amino Acid Mismatches That Distinguish Divergent HLA-A Allele Lineages Confer Incremental Risk of Kidney Allograft Failure Independent of Class II Mismatches David Leeser, United States Improving the Fit: Adding County Deprivation Index to SRTR Graft Outcomes David Leeser, United States Improving the Fit: Adding County Deprivation Index to SRTR Graft Outcomes Benjamin Bizer, United States Kidney Donation: Public Engagement and Readability of Online Resources - An AI-Driven Sentiment and Content Analysis Benjamin Bizer, United States Kidney Donation: Public Engagement and Readability of Online Resources - An AI-Driven Sentiment and Content Analysis
12:15-15:30	12	12 12:15 Oral Abstract: Kidney Biomarkers, Imaging, and Engineering Full Details Marta Sablik, France Association of Donor-Derived Cell-Free DNA with Microvascular Inflammation Phenotypes in Kidney Allografts Marta Sablik, France Association of Donor-Derived Cell-Free DNA with Microvascular Inflammation Phenotypes in Kidney Allografts John Fallon, United Kingdom Characterising Prognostic Complement Biomarkers during Clinical Normothermic Machine Perfusion for Renal Transplantation John Fallon, United Kingdom Characterising Prognostic Complement Biomarkers during Clinical Normothermic Machine Perfusion for Renal Transplantation Romain Brousse, France Performance of Integrative dd-cfDNA in Detecting Rejection Based on the Updated Banff 2022 Classification Romain Brousse, France Performance of Integrative dd-cfDNA in Detecting Rejection Based on the Updated Banff 2022 Classification Akhil Singla, United States Using Torque Teno Virus as a Serial Monitoring Tool Representing the Net State of Immunosuppression for Kidney Recipients Akhil Singla, United States Using Torque Teno Virus as a Serial Monitoring Tool Representing the Net State of Immunosuppression for Kidney Recipients Chethan Ashokkumar, United States A Multiclass Machine Learning Model with Allospecific B-Cells and T-Cells Predicts Antibody- and T-Cell-Mediated Rejection (ABMR, TCMR) After Kidney Transplantation (KT) Chethan Ashokkumar, United States A Multiclass Machine Learning Model with Allospecific B-Cells and T-Cells Predicts Antibody- and T-Cell-Mediated Rejection (ABMR, TCMR) After Kidney Transplantation (KT) Chirag Parikh, United States Improving the Prediction of Deceased Donor Allograft Function with Donor Urinary Biomarkers Chirag Parikh, United States Improving the Prediction of Deceased Donor Allograft Function with Donor Urinary Biomarkers Elena Crespo, Spain Longitudinal Assessment of Alloreactive Memory T and B Cells in the EUTRAIN Kidney Transplant Cohort Elena Crespo, Spain Longitudinal Assessment of Alloreactive Memory T and B Cells in the EUTRAIN Kidney Transplant Cohort Anil Bhalla, India Early Post-Transplant TTV Load: A Biomarker of Immunosuppression and Infection Anil Bhalla, India Early Post-Transplant TTV Load: A Biomarker of Immunosuppression and Infection
16:30-17:45	10	10 16:30 Oral Abstract: Immunomodulation Full Details Abraham Matar, United States A Novel Anti-CD154 Nonantibody Fusion Protein Facilitates Long Term Pig to Primate Kidney Xenograft Survival Abraham Matar, United States A Novel Anti-CD154 Nonantibody Fusion Protein Facilitates Long Term Pig to Primate Kidney Xenograft Survival Tatsuo Kawai, United States Multiple Human Transgenes Prolong Survival of Triple-Carbohydrate Knockout Porcine Kidney Xenografts in Nonhuman Primates Tatsuo Kawai, United States Multiple Human Transgenes Prolong Survival of Triple-Carbohydrate Knockout Porcine Kidney Xenografts in Nonhuman Primates Chao Yang, People's Republic of China NR4A1 Drives Immunoregulatory Macrophage Development to Protect Renal Allografts by Restraining Tissue-Resident Memory T Cell Activity Chao Yang, People's Republic of China NR4A1 Drives Immunoregulatory Macrophage Development to Protect Renal Allografts by Restraining Tissue-Resident Memory T Cell Activity Sayantan Bose, United States Immunoevasion by Intragraft Semaphorin 3F Following Transplantation Sayantan Bose, United States Immunoevasion by Intragraft Semaphorin 3F Following Transplantation Madonna Anggelia, Taiwan Targeting HIF-1α and miR-17-92 in CD4⁺ T Cells to Improve Vascularized Composite Allotransplantation Outcomes Madonna Anggelia, Taiwan Targeting HIF-1α and miR-17-92 in CD4⁺ T Cells to Improve Vascularized Composite Allotransplantation Outcomes YUKI MARUYAMA, United States Absence of Recipient NKG2D or Allograft Donor Rae-1 Abrogates Acute Antibody-Mediated Rejection of Kidney Allografts in a Novel Mouse Mode YUKI MARUYAMA, United States Absence of Recipient NKG2D or Allograft Donor Rae-1 Abrogates Acute Antibody-Mediated Rejection of Kidney Allografts in a Novel Mouse Mode Jean Kwun, United States Immunoproteasome Inhibitor (KZR-616) Desensitization and Maintenance Therapy in Highly Sensitized Non-Human Primates Jean Kwun, United States Immunoproteasome Inhibitor (KZR-616) Desensitization and Maintenance Therapy in Highly Sensitized Non-Human Primates Kassandra Baron, United States Allogeneic Reparative Treg Cell Therapy Augments Local Reparative Macrophages and Promotes Tissue Repair After Lung Injury Kassandra Baron, United States Allogeneic Reparative Treg Cell Therapy Augments Local Reparative Macrophages and Promotes Tissue Repair After Lung Injury
16:30-17:45	12	12 16:30 Oral Abstract: From Pre-Clinical Studies to First in Human: What's New on the Horizon Full Details Masaki Komatsu, United States Adaptive Responses within the Graft Endothelial Cell as a Determinant of Long-Term Survival Masaki Komatsu, United States Adaptive Responses within the Graft Endothelial Cell as a Determinant of Long-Term Survival Hengcheng Zhang, United States Intrarenal T Follicular Helper Cells Promote Alloimmune Injury and Fibrosis After Kidney Transplantation Hengcheng Zhang, United States Intrarenal T Follicular Helper Cells Promote Alloimmune Injury and Fibrosis After Kidney Transplantation Leonardo Riella, United States First and Second Genetically Modified Pig Kidney Xenotransplants in Living Human Recipients: Immunological and Physiological Insights Leonardo Riella, United States First and Second Genetically Modified Pig Kidney Xenotransplants in Living Human Recipients: Immunological and Physiological Insights Kenneth Brayman, United States IL-13: A New Ally in the Fight for Islet Graft Survival Kenneth Brayman, United States IL-13: A New Ally in the Fight for Islet Graft Survival Wayne Hancock, United States Five Strategies to Use IL-2 Muteins to Expand Foxp3+ Treg Cells and Promote Long-Term Cardiac and Renal Allograft Survival in Naïve and Sensitized Recipients Wayne Hancock, United States Five Strategies to Use IL-2 Muteins to Expand Foxp3+ Treg Cells and Promote Long-Term Cardiac and Renal Allograft Survival in Naïve and Sensitized Recipients Daniel Calabrese, United States Novel Anti-CD94 Treatment Reduces Kidney Ischemia-Reperfusion Injury and Subsequent Acute Lung Injury Daniel Calabrese, United States Novel Anti-CD94 Treatment Reduces Kidney Ischemia-Reperfusion Injury and Subsequent Acute Lung Injury Bayan Alsairafi, United States Effects of Targeting the Cullin RING E3 Ubiquitin Ligase Using MLN4924 on the Alloimmune Response Bayan Alsairafi, United States Effects of Targeting the Cullin RING E3 Ubiquitin Ligase Using MLN4924 on the Alloimmune Response Jean Kwun, United States An IL-2 Mutein (VIS171) Induces Regulatory T Cells and Prolongs Survival in a Rhesus Kidney Transplant Model Jean Kwun, United States An IL-2 Mutein (VIS171) Induces Regulatory T Cells and Prolongs Survival in a Rhesus Kidney Transplant Model
16:30-17:45	8	8 16:30 Oral Abstract: Lifelong Viral Invaders in Transplant Full Details Mayyadah Alabdely, United States Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single-Center Experience Mayyadah Alabdely, United States Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single-Center Experience Edward Vizcarra, United States T Cell Profiling Reveals Functional Immune Defects in Pediatric Transplant Recipients with Chronic Epstein-Barr Virus DNAemia Edward Vizcarra, United States T Cell Profiling Reveals Functional Immune Defects in Pediatric Transplant Recipients with Chronic Epstein-Barr Virus DNAemia Avery Koi, United States From Incurable to Successful Transplantation: Long Term Outcomes in HIV+ vs HIV- Liver Transplant Recipients at 1, 3, and 5 Years - A Retrospective Analysis Avery Koi, United States From Incurable to Successful Transplantation: Long Term Outcomes in HIV+ vs HIV- Liver Transplant Recipients at 1, 3, and 5 Years - A Retrospective Analysis Daniel Dulek, United States Multicenter Prospective Cohort Study of CMV T Cell Immunity and First Post-Transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients Daniel Dulek, United States Multicenter Prospective Cohort Study of CMV T Cell Immunity and First Post-Transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients Bailey Conkey, United States Clinical Significance of Persistent Low-Level CMV DNAemia in Solid Organ Transplantation Bailey Conkey, United States Clinical Significance of Persistent Low-Level CMV DNAemia in Solid Organ Transplantation Mingqian Feng, People's Republic of China A Novel gp350/CD89-Targeted Bispecific Antibody Against Epstein-Barr Virus (EBV) Infection and EBV-Associated Hematological Diseases Mingqian Feng, People's Republic of China A Novel gp350/CD89-Targeted Bispecific Antibody Against Epstein-Barr Virus (EBV) Infection and EBV-Associated Hematological Diseases Deepali Kumar, Canada Disseminated Varicella-Zoster Virus Infection in Transplant Recipients: A 10-Year Review Deepali Kumar, Canada Disseminated Varicella-Zoster Virus Infection in Transplant Recipients: A 10-Year Review Kapil Saharia, United States Risk of De Novo Hepatitis B Infection in HBsAg- Recipients of HBcAb+/HBsAg- Liver Grafts Who Discontinue Antiviral Prophylaxis Kapil Saharia, United States Risk of De Novo Hepatitis B Infection in HBsAg- Recipients of HBcAb+/HBsAg- Liver Grafts Who Discontinue Antiviral Prophylaxis
16:30-17:45	153	153 16:30 Oral Abstract: Grafts and Germs: Infectious Challenges in Transplant Medicine Full Details NITHYE PARVATHY, India Shifting Trends in Terminal Infections of Post Renal Transplant Recipients: Insights from an Autopsy Study NITHYE PARVATHY, India Shifting Trends in Terminal Infections of Post Renal Transplant Recipients: Insights from an Autopsy Study Lucas Garcias, Argentina Preservation Fluid Cultures in Simultaneous Pancreas and Kidney Transplantation. Twenty Years of Experience Lucas Garcias, Argentina Preservation Fluid Cultures in Simultaneous Pancreas and Kidney Transplantation. Twenty Years of Experience Joanna Schaenman, United States Frailty by Chart Review Can Predict Infection in Kidney Transplant Recipients: A Multicenter Study through the AST IDCOP Joanna Schaenman, United States Frailty by Chart Review Can Predict Infection in Kidney Transplant Recipients: A Multicenter Study through the AST IDCOP Laura Donadeu Casassas, Spain T-Cell Exhaustion Impacts Specific Adaptive Responses After Vaccination in Solid Organ Transplant Laura Donadeu Casassas, Spain T-Cell Exhaustion Impacts Specific Adaptive Responses After Vaccination in Solid Organ Transplant Gang Huang, People's Republic of China Single-Cell RNA Sequencing Reveals the Immune Microenvironment of BK Polyomavirus Nephropathy Gang Huang, People's Republic of China Single-Cell RNA Sequencing Reveals the Immune Microenvironment of BK Polyomavirus Nephropathy Kapil Saharia, United States Hepatitis B Vaccine Compliance and Seroresponse Rates Among Solid Organ Transplant Recipients Receiving Recombinant versus Adjuvanted HBV Vaccine Kapil Saharia, United States Hepatitis B Vaccine Compliance and Seroresponse Rates Among Solid Organ Transplant Recipients Receiving Recombinant versus Adjuvanted HBV Vaccine Anthony Langone, United States Stool Studies in Kidney Transplant Recipients: A Single-Center Retrospective Review of 1,000 Cases Anthony Langone, United States Stool Studies in Kidney Transplant Recipients: A Single-Center Retrospective Review of 1,000 Cases Daniela Barisano, United States Influenza Vaccine Effectiveness and Disease Burden in Children and Adolescents with Solid Organ Transplant: 2018-2024 Daniela Barisano, United States Influenza Vaccine Effectiveness and Disease Burden in Children and Adolescents with Solid Organ Transplant: 2018-2024
16:30-17:45	20	20 16:30 Oral Abstract: The Future of Heart Transplant Surveillance? Full Details Philip Halloran, Canada Defining Relationships Among Tests for Heart Transplant Antibody-Mediated Rejection Philip Halloran, Canada Defining Relationships Among Tests for Heart Transplant Antibody-Mediated Rejection Jon Kobashigawa, United States High Level Donor Derived Cell-Free DNA in Asymptomatic Patients After Heart Transplant - Does It Matter? Jon Kobashigawa, United States High Level Donor Derived Cell-Free DNA in Asymptomatic Patients After Heart Transplant - Does It Matter? Kris Oreschak, United States Prognostic Value of Donor-Derived Cell-Free DNA in Combination with HLA1 and HLA2 Donor Specific Antibodies After Heart Transplant Kris Oreschak, United States Prognostic Value of Donor-Derived Cell-Free DNA in Combination with HLA1 and HLA2 Donor Specific Antibodies After Heart Transplant Kris Oreschak, United States Leveraging Longitudinal Donor-Derived Cell-Free DNA and Gene Expression Profiling Data for Acute Cellular Rejection Diagnosis After Heart Transplant Kris Oreschak, United States Leveraging Longitudinal Donor-Derived Cell-Free DNA and Gene Expression Profiling Data for Acute Cellular Rejection Diagnosis After Heart Transplant Kris Oreschak, United States Antibody Mediated Rejection in the Contemporary Donor-Derived Cell-Free DNA Era: An Analysis of the Surveillance HeartCare Outcomes Registry Kris Oreschak, United States Antibody Mediated Rejection in the Contemporary Donor-Derived Cell-Free DNA Era: An Analysis of the Surveillance HeartCare Outcomes Registry Kris Oreschak, United States Impact of Persistently Elevated Simultaneous Gene Expression Profiling and Donor-Derived Cell-Free DNA on Future Clinical Events Kris Oreschak, United States Impact of Persistently Elevated Simultaneous Gene Expression Profiling and Donor-Derived Cell-Free DNA on Future Clinical Events Alessia Giarraputo, France Molecular Classification System for Cardiac Allograft Rejection is Positively Associated with the Pathology Severity of Rejection Alessia Giarraputo, France Molecular Classification System for Cardiac Allograft Rejection is Positively Associated with the Pathology Severity of Rejection Stephanie Golob, United States Association of ImmuKnow with Post-Transplant Coronary Artery Vasculopathy Stephanie Golob, United States Association of ImmuKnow with Post-Transplant Coronary Artery Vasculopathy
16:30-17:45	9	9 16:30 Oral Abstract: Pharmacotherapy and Adherence Full Details Mark Wakefield, United States The SystemCHANGE^TM Intervention Improves Medication-Taking Habit: A Secondary Analysis of the MAGIC Studies Mark Wakefield, United States The SystemCHANGE^TM Intervention Improves Medication-Taking Habit: A Secondary Analysis of the MAGIC Studies Lidan Gu, United States The Characteristics of Early Medication Level Variability in Pediatric Kidney Transplant Recipients Lidan Gu, United States The Characteristics of Early Medication Level Variability in Pediatric Kidney Transplant Recipients Sunjae Bae, United States Evidence-Based Individualization of Early Steroid Withdrawal and Its Association with Mortality After Kidney Transplantation Sunjae Bae, United States Evidence-Based Individualization of Early Steroid Withdrawal and Its Association with Mortality After Kidney Transplantation Nicole Wilson, United States Predicting Unbound Tacrolimus Concentrations during Pregnancy Nicole Wilson, United States Predicting Unbound Tacrolimus Concentrations during Pregnancy Ann Kataria, United States Utilizing EHR-Integrated Proportion of Days Covered (PDC) to Monitor Post Kidney Transplant Medication Adherence Ann Kataria, United States Utilizing EHR-Integrated Proportion of Days Covered (PDC) to Monitor Post Kidney Transplant Medication Adherence Kelsey Coffman, United States More Than Numbers: Predictors of Success in Belatacept Conversion in Kidney Transplant Recipients Kelsey Coffman, United States More Than Numbers: Predictors of Success in Belatacept Conversion in Kidney Transplant Recipients Christine Wolesensky, United States Improved Tacrolimus XR Dosing and Monitoring Outcomes with a Genotype-Based Dosing Algorithm vs. Weight Based Dosing Christine Wolesensky, United States Improved Tacrolimus XR Dosing and Monitoring Outcomes with a Genotype-Based Dosing Algorithm vs. Weight Based Dosing Jiqiu Wen, People's Republic of China Telitacicept Treatment for Active Antibody-Mediated Rejection: Case Series Report Jiqiu Wen, People's Republic of China Telitacicept Treatment for Active Antibody-Mediated Rejection: Case Series Report
16:30-17:45	22	22 16:30 Oral Abstract: Education Full Details Jennifer Wainright, United States Characteristics Associated with Acceptance of Porcine Xenotransplantation Jennifer Wainright, United States Characteristics Associated with Acceptance of Porcine Xenotransplantation Cory Schaffhausen, United States The Impact of Transplant Metric Visual Icons on Patient Decisions to Select a Transplant Center Cory Schaffhausen, United States The Impact of Transplant Metric Visual Icons on Patient Decisions to Select a Transplant Center Jesse Schold, United States Censoring Scientific Dissemination in Transplantation Jesse Schold, United States Censoring Scientific Dissemination in Transplantation Akshta Pai, United States Bridging the Gap: Assessing Knowledge, Preparedness, and Regulatory Perspectives on Genetically Engineered Pig-to-Human Xenotransplants Among Transplant Specialists Akshta Pai, United States Bridging the Gap: Assessing Knowledge, Preparedness, and Regulatory Perspectives on Genetically Engineered Pig-to-Human Xenotransplants Among Transplant Specialists Gina Jamero, United States Advanced Practice Provider Transplant Certification - Results of a Needs Assessment Survey Gina Jamero, United States Advanced Practice Provider Transplant Certification - Results of a Needs Assessment Survey Saad Hussain, United States Bridging the Gap: A Comprehensive Summer Student Immersion Program in Transplantation Saad Hussain, United States Bridging the Gap: A Comprehensive Summer Student Immersion Program in Transplantation Bradon Nave, United States Research Exclusive Donation: Revolutionizing Medical Research through Organ Procurement Organizations Bradon Nave, United States Research Exclusive Donation: Revolutionizing Medical Research through Organ Procurement Organizations Kiran Goli, United States Innovative AI-Driven Transplant Board Review Series: Enhancing Fellow Engagement and Learning in Nephrology Fellowship Training Kiran Goli, United States Innovative AI-Driven Transplant Board Review Series: Enhancing Fellow Engagement and Learning in Nephrology Fellowship Training
16:30-17:45	154	154 16:30 Oral Abstract: Expanding the Donor Pool Full Details Chase Wehrle, United States Cost Effectiveness Analysis and Clinical Outcomes of Back-to-Base Normothermic Machine Perfusion with and without FMN: A Multi-Center Risk-Matched Study of 967 Patients Chase Wehrle, United States Cost Effectiveness Analysis and Clinical Outcomes of Back-to-Base Normothermic Machine Perfusion with and without FMN: A Multi-Center Risk-Matched Study of 967 Patients Kliment Bozhilov, United States A UNOS Database Outcomes Analysis of DCD Liver Transplantation Using Sequential Normothermic Regional Perfusion and Normothermic Machine Perfusion versus NRP Alone Kliment Bozhilov, United States A UNOS Database Outcomes Analysis of DCD Liver Transplantation Using Sequential Normothermic Regional Perfusion and Normothermic Machine Perfusion versus NRP Alone Alexander Cortez, United States Impact of Normothermic Machine Perfusion on Liver Transplant Outcomes: A Multi-Institutional Experience from the National Organ Perfusion Registry Alexander Cortez, United States Impact of Normothermic Machine Perfusion on Liver Transplant Outcomes: A Multi-Institutional Experience from the National Organ Perfusion Registry Haseeb Zubair, United States Molecular Differences in Injured Cholangiocytes during Cold Static Storage of Livers from Standard and Extended Criteria Donors Haseeb Zubair, United States Molecular Differences in Injured Cholangiocytes during Cold Static Storage of Livers from Standard and Extended Criteria Donors CHUNBAO JIAO, United States Optimizing Donation After Circulatory Death (DCD) Liver Preservation with Resveratrol during Machine Perfusion CHUNBAO JIAO, United States Optimizing Donation After Circulatory Death (DCD) Liver Preservation with Resveratrol during Machine Perfusion Anji Wall, United States NRP DCD Liver Grafts Yield Equal Outcomes of DBD Liver Grafts: A Single US Center Experience Anji Wall, United States NRP DCD Liver Grafts Yield Equal Outcomes of DBD Liver Grafts: A Single US Center Experience David Axelrod, United States Economic Assessment of Hypothermic Oxygenated Machine Perfusion in Liver Transplantation David Axelrod, United States Economic Assessment of Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Anji Wall, United States The Impact of a Transplant-Center Based Normothermic Regional Perfusion Program on Liver Transplant Volume and Finances Anji Wall, United States The Impact of a Transplant-Center Based Normothermic Regional Perfusion Program on Liver Transplant Volume and Finances
16:30-17:45	155	155 16:30 Oral Abstract: Liver Malignancies Full Details Yuki Imaoka, Japan IL-37 Enhances Immunotherapeutic Potential of Off-the-Shelf Liver NK Cells for Hepatocellular Carcinoma: Overcoming Cryopreservation Challenges Yuki Imaoka, Japan IL-37 Enhances Immunotherapeutic Potential of Off-the-Shelf Liver NK Cells for Hepatocellular Carcinoma: Overcoming Cryopreservation Challenges Sabrina Leo, Canada Retinoid Acid Receptor-Related Orphan Receptor Gamma (RORγ): A Potential Target in Transplantation Oncology to Expand Therapeutic Options for Patients with Hepatocellular Carcinoma (HCC) Sabrina Leo, Canada Retinoid Acid Receptor-Related Orphan Receptor Gamma (RORγ): A Potential Target in Transplantation Oncology to Expand Therapeutic Options for Patients with Hepatocellular Carcinoma (HCC) Zijie Zhang, People's Republic of China Integrative Multi-Omics Analysis Identifies Evolving Landscape and Potential Targets for Recurrent HCC After Liver Transplant Zijie Zhang, People's Republic of China Integrative Multi-Omics Analysis Identifies Evolving Landscape and Potential Targets for Recurrent HCC After Liver Transplant Allison Kwong, United States Fewer Liver Transplant Recipients with HCC Are Waiting ≥6 Months for Transplant in the United States Allison Kwong, United States Fewer Liver Transplant Recipients with HCC Are Waiting ≥6 Months for Transplant in the United States Jin-Chiao Lee, Taiwan Risk Stratification Based on Non-Transplantable Recurrence for Treatment Allocation in Child-Pugh A Patients with Hepatocellular Carcinoma Jin-Chiao Lee, Taiwan Risk Stratification Based on Non-Transplantable Recurrence for Treatment Allocation in Child-Pugh A Patients with Hepatocellular Carcinoma Jiyoung Kim, Korea Post-Transplant Malignancy Risk in Liver Transplantation Recipients: A Nationwide Matched Cohort Study Comparing Liver Cancer and Non-Cancer Recipients with the General Population Jiyoung Kim, Korea Post-Transplant Malignancy Risk in Liver Transplantation Recipients: A Nationwide Matched Cohort Study Comparing Liver Cancer and Non-Cancer Recipients with the General Population Matthew Byrne, United States Tumor Biology-Driven Recipient Selection Determines Outcomes in Liver Transplantation for Colorectal Liver Metastases Matthew Byrne, United States Tumor Biology-Driven Recipient Selection Determines Outcomes in Liver Transplantation for Colorectal Liver Metastases
16:30-17:45	4	4 16:30 Oral Abstract: Deceased Donor Kidney Procurement, Preservation, and Organ Manipulation Full Details Matthew Holzner, United States Rescuing Hard-to-Place Kidneys Using a Normothermic Machine Perfusion Service: Results of the OPTIMAL Study Matthew Holzner, United States Rescuing Hard-to-Place Kidneys Using a Normothermic Machine Perfusion Service: Results of the OPTIMAL Study Yuki Bekki, United States The Impact of Normothermic Regional Perfusion on the Utilization and Post-Transplant Outcomes for Kidney Transplantation Yuki Bekki, United States The Impact of Normothermic Regional Perfusion on the Utilization and Post-Transplant Outcomes for Kidney Transplantation Samy Riad, United States Evaluating the Impact of Machine Perfusion on Primary Nonfunction Rates in Deceased Donor Kidneys with Discarded Contralateral Mate Samy Riad, United States Evaluating the Impact of Machine Perfusion on Primary Nonfunction Rates in Deceased Donor Kidneys with Discarded Contralateral Mate Tom Darius, Belgium National Implementation of HMP Increases Local Kidney Utilisation Rate and is Highly Cost-Effectiveness Tom Darius, Belgium National Implementation of HMP Increases Local Kidney Utilisation Rate and is Highly Cost-Effectiveness Nicholas Blount, United States When Good Kidneys Pump Poorly: Why Some High-Resistance Organs Deserve a Chance Nicholas Blount, United States When Good Kidneys Pump Poorly: Why Some High-Resistance Organs Deserve a Chance Sue Fu, United States Effects of Sequential Hypothermic Machine Perfusion After Normothermic Regional Perfusion and Donation After Circulatory Death on Kidney Transplant Outcomes Sue Fu, United States Effects of Sequential Hypothermic Machine Perfusion After Normothermic Regional Perfusion and Donation After Circulatory Death on Kidney Transplant Outcomes Jennifer Philip, United States Novel Perfusion Parameters Predict Early and Late Renal Allograft Outcomes Jennifer Philip, United States Novel Perfusion Parameters Predict Early and Late Renal Allograft Outcomes Marlene Pühringer-Sturmayr, Austria Automated Multi-Sensor Kidney Perfusion Device Enables 5-Day Normothermic Preservation of Human and Porcine Kidneys Marlene Pühringer-Sturmayr, Austria Automated Multi-Sensor Kidney Perfusion Device Enables 5-Day Normothermic Preservation of Human and Porcine Kidneys
16:30-17:45	24	24 16:30 Oral Abstract: Kidney Immunosuppression Maintenance; Tolerance Full Details Christian Larsen, United States Selective Implementation of Belatacept Every Other Month as Standard Care Option with Use of cfDNA Testing Christian Larsen, United States Selective Implementation of Belatacept Every Other Month as Standard Care Option with Use of cfDNA Testing Alex Rogers, United States A Donor Derived Cell Free DNA Approach to Immunosuppression Minimization in Elderly Kidney Transplant Recipients Alex Rogers, United States A Donor Derived Cell Free DNA Approach to Immunosuppression Minimization in Elderly Kidney Transplant Recipients Elizabeth Hendren, Canada A Matched Cohort Analysis of Kidney Transplant Recipients Treated with Depleting and Non-Depleting Antibody Induction and Early Corticosteroid Cessation Elizabeth Hendren, Canada A Matched Cohort Analysis of Kidney Transplant Recipients Treated with Depleting and Non-Depleting Antibody Induction and Early Corticosteroid Cessation Marta Crespo, Spain Pretransplant Response to Immunosuppressants Measured with Immunobiogram Predicts First-Year Rejection in Kidney Transplant Recipients Marta Crespo, Spain Pretransplant Response to Immunosuppressants Measured with Immunobiogram Predicts First-Year Rejection in Kidney Transplant Recipients Alex Zendel, United States De Novo Belatacept Maintenance Immunosuppression Protocol as a Strategy to Increase Utilization of Kidney Allografts - 5-Year Experience Alex Zendel, United States De Novo Belatacept Maintenance Immunosuppression Protocol as a Strategy to Increase Utilization of Kidney Allografts - 5-Year Experience Zahraa Khan, United States HLA-Epitope Mismatches and De Novo Donor Specific Antibodies (dDSA) Development Post-BK Virus Nephropathy Zahraa Khan, United States HLA-Epitope Mismatches and De Novo Donor Specific Antibodies (dDSA) Development Post-BK Virus Nephropathy Guillaume Onyeaghala, United States Gut Microbiome Meta-Transcriptomics Associated with Mycophenolate Mofetil Enterohepatic Recirculation in Kidney Transplant Recipients Guillaume Onyeaghala, United States Gut Microbiome Meta-Transcriptomics Associated with Mycophenolate Mofetil Enterohepatic Recirculation in Kidney Transplant Recipients Daniel Schuster, United States Subcutaneous Administration of a CD28 Co-Stimulation Blocker Demonstrates Efficacy in an NHP Model of Kidney Allotransplantation Daniel Schuster, United States Subcutaneous Administration of a CD28 Co-Stimulation Blocker Demonstrates Efficacy in an NHP Model of Kidney Allotransplantation
16:30-17:45	25	25 16:30 Oral Abstract: Living Donor Kidney Selection Full Details Badi Rawashdeh, United States Comparative Outcomes Analysis of Living Kidney Donors With and Without of Kidney Stones: A Propensity-Matched Study Badi Rawashdeh, United States Comparative Outcomes Analysis of Living Kidney Donors With and Without of Kidney Stones: A Propensity-Matched Study Karny Ilan, Israel Exploring Why Potential Living Kidney Donor Candidates Fail to Complete the Donation Process: A Comparison Between Related and Unrelated Donors Karny Ilan, Israel Exploring Why Potential Living Kidney Donor Candidates Fail to Complete the Donation Process: A Comparison Between Related and Unrelated Donors Taiki Ogasa, Japan Application of CT Imaging Analysis Technology in Kidney Transplantation Taiki Ogasa, Japan Application of CT Imaging Analysis Technology in Kidney Transplantation Luke Shen, United States Obese Living Kidney Donors - Weighing the Weight on Donors and Recipients Outcomes Luke Shen, United States Obese Living Kidney Donors - Weighing the Weight on Donors and Recipients Outcomes Hannah Kek, Singapore Comparative Analysis of Computerised Tomography Volumetry vs. Nuclear Imaging (Dimercaptosuccinic Acid) Scan in Predicting Early Post-Donation Renal Function Using Split Renal Function Hannah Kek, Singapore Comparative Analysis of Computerised Tomography Volumetry vs. Nuclear Imaging (Dimercaptosuccinic Acid) Scan in Predicting Early Post-Donation Renal Function Using Split Renal Function Momoko Akasaki, Japan Donor-Derived Nephritis on Pretransplant Biopsy Does Not Impair Posttransplant Renal Function in Recipients or Donors Momoko Akasaki, Japan Donor-Derived Nephritis on Pretransplant Biopsy Does Not Impair Posttransplant Renal Function in Recipients or Donors Elizabeth Hendren, Canada The Absence of Sex Related Differences in Pre-Donation eGFR Indicate a Need for Standardization of Living Donor Selection Criteria Elizabeth Hendren, Canada The Absence of Sex Related Differences in Pre-Donation eGFR Indicate a Need for Standardization of Living Donor Selection Criteria Eoghan White, Canada Older Living Kidney Donors ≥ 65 Years Are Infrequently Utilized Despite Excellent Outcomes Eoghan White, Canada Older Living Kidney Donors ≥ 65 Years Are Infrequently Utilized Despite Excellent Outcomes
16:30-17:45	21	21 16:30 Oral Abstract: Kidney Rejection Pathology Full Details Karolien Wellekens, Belgium Intimal Arteritis ('v') in Kidney Transplant Rejection: Multicenter Clinical and Molecular Evidence Challenging the Banff 2022 Classification Karolien Wellekens, Belgium Intimal Arteritis ('v') in Kidney Transplant Rejection: Multicenter Clinical and Molecular Evidence Challenging the Banff 2022 Classification Ondrej Viklicky, Czech Republic Biopsy-Based Transcriptomics of Banff 2022 Antibody-Mediated Rejection Categories Ondrej Viklicky, Czech Republic Biopsy-Based Transcriptomics of Banff 2022 Antibody-Mediated Rejection Categories Emmett Wong, Singapore Microvascular Inflammation Alters the Prognosis Associated with T-Cell-Mediated Rejection Emmett Wong, Singapore Microvascular Inflammation Alters the Prognosis Associated with T-Cell-Mediated Rejection Lukas Weidmann, Switzerland Molecular Interpretation, Archetype Analysis, and Injury Dimensions Improve Prognostication From Kidney Allograft Biopsies Classified According to Banff 2022 Lukas Weidmann, Switzerland Molecular Interpretation, Archetype Analysis, and Injury Dimensions Improve Prognostication From Kidney Allograft Biopsies Classified According to Banff 2022 Ilkka Helanterä, Finland Findings and Significance of Early Follow-Up Biopsies After Treatment of Acute Rejection in Kidney Transplant Recipients Ilkka Helanterä, Finland Findings and Significance of Early Follow-Up Biopsies After Treatment of Acute Rejection in Kidney Transplant Recipients Parmjeet Randhawa, United States Chronic Active TCMR (ca-TCMR) in the Kidney: Definition, Prevalence, Concurrent Acute TCMR and Banff Activity-Chronicity Indices Parmjeet Randhawa, United States Chronic Active TCMR (ca-TCMR) in the Kidney: Definition, Prevalence, Concurrent Acute TCMR and Banff Activity-Chronicity Indices Mariko Hunter, United States Clinical Outcomes Based on Tissue Transcriptomics-Guided Management in Real-World Kidney Transplant Cohort Mariko Hunter, United States Clinical Outcomes Based on Tissue Transcriptomics-Guided Management in Real-World Kidney Transplant Cohort Valentin Goutaudier, France Multimodal and Spatial Profiling of Microvascular Inflammation in Kidney Allografts Valentin Goutaudier, France Multimodal and Spatial Profiling of Microvascular Inflammation in Kidney Allografts
16:30-17:45	11	11 16:30 Oral Abstract: Breathing New Life: Improving Outcomes in Lung Transplantation Full Details Darren Stewart, United States Recipient and Donor Factors Associated with BOS/CLAD-Free Graft Survival vs. Graft Survival Alone Darren Stewart, United States Recipient and Donor Factors Associated with BOS/CLAD-Free Graft Survival vs. Graft Survival Alone Marc Raynaud, France Trajectories of FEV1 After Lung Transplantation and Patient Outcomes Marc Raynaud, France Trajectories of FEV1 After Lung Transplantation and Patient Outcomes Justin Wang, United States Every Minute Matters: The Impact of Donor Agonal Time on Recipient Outcomes in DCD Lung Transplantation Justin Wang, United States Every Minute Matters: The Impact of Donor Agonal Time on Recipient Outcomes in DCD Lung Transplantation Chelsea Hawkins, United States Continuous Distribution of Lungs Decreases Waiting List Mortality without Compromising 6-Month Post-Transplant Outcomes Chelsea Hawkins, United States Continuous Distribution of Lungs Decreases Waiting List Mortality without Compromising 6-Month Post-Transplant Outcomes Samantha Weiss, United States Summary of Trends in Pediatric Transplantation under Lung Continuous Distribution Samantha Weiss, United States Summary of Trends in Pediatric Transplantation under Lung Continuous Distribution Kiran Thirukonda, United States Impact of Ex Vivo Lung Perfusion on Post-Transplant Graft Survival: A Retrospective Analysis of UNOS Data Kiran Thirukonda, United States Impact of Ex Vivo Lung Perfusion on Post-Transplant Graft Survival: A Retrospective Analysis of UNOS Data Dominic Emerson, United States The Worldwide Robotic Lung Transplantation Experience To-Date: Outcomes in the First Three Centers Dominic Emerson, United States The Worldwide Robotic Lung Transplantation Experience To-Date: Outcomes in the First Three Centers Mohamed Elrefaei, United States Donor HLA-Derived Indirect T Cell Epitope and Surface-Accessible Amino Acid Mismatch Loads Predict Lung Allograft Dysfunction Mohamed Elrefaei, United States Donor HLA-Derived Indirect T Cell Epitope and Surface-Accessible Amino Acid Mismatch Loads Predict Lung Allograft Dysfunction
16:30-17:45	23	23 16:30 Oral Abstract: Pancreas Full Details Farah Abuazzam, United States Outcomes and Predictors of Pancreas Graft Survival in Simultaneous Pancreas-Kidney Transplant Recipients: A Contemporary Analysis of OPTN Database Farah Abuazzam, United States Outcomes and Predictors of Pancreas Graft Survival in Simultaneous Pancreas-Kidney Transplant Recipients: A Contemporary Analysis of OPTN Database Todd Brennan, United States Comparable Outcomes of Pancreas Transplants from Donation After Circulatory Death Compared to Brain Death Donors Todd Brennan, United States Comparable Outcomes of Pancreas Transplants from Donation After Circulatory Death Compared to Brain Death Donors Todd Brennan, United States Outcomes of Highly Sensitized Pancreas Transplant Recipients in the Modern Era Todd Brennan, United States Outcomes of Highly Sensitized Pancreas Transplant Recipients in the Modern Era Dante Puntiel, United States Challenges in Pancreas Transplantation for Obese Recipients with Type II Diabetes Dante Puntiel, United States Challenges in Pancreas Transplantation for Obese Recipients with Type II Diabetes Todd Brennan, United States Pancreas Transplantation in Type 2 Diabetics is Associated with Lower Rates of Graft Rejection and Graft Loss Compared with Type 1 Diabetics Todd Brennan, United States Pancreas Transplantation in Type 2 Diabetics is Associated with Lower Rates of Graft Rejection and Graft Loss Compared with Type 1 Diabetics Ali Abbasi, United States A Multicenter Study of Weight Loss and Side Effects in Pancreas Transplant Recipients Treated with GLP-1 Receptor Agonists Ali Abbasi, United States A Multicenter Study of Weight Loss and Side Effects in Pancreas Transplant Recipients Treated with GLP-1 Receptor Agonists Sandesh Parajuli, United States Positive Malnutrition Risk Factors Pre-Transplant Are Associated with Adverse Outcomes After Simultaneous Kidney and Pancreas and Solitary Pancreas Transplantation Sandesh Parajuli, United States Positive Malnutrition Risk Factors Pre-Transplant Are Associated with Adverse Outcomes After Simultaneous Kidney and Pancreas and Solitary Pancreas Transplantation Argyrios Asderakis, United Kingdom Beta Cell Specific Cell Free DNA and Trypsinogen for the Diagnosis of Rejection in Pancreas Transplantation The EMPAR Study Argyrios Asderakis, United Kingdom Beta Cell Specific Cell Free DNA and Trypsinogen for the Diagnosis of Rejection in Pancreas Transplantation The EMPAR Study

07:00-08:00

22

07:00

Invited Symposia: “I’m Bringing Sexy Back”: Improving Fellows’ Interest in Solid Organ Transplantation

Samira Farouk, United States
“I’m Loving It”: How Do We Increase Exposure for Medical Students, Residents and Fellows

Anjana Pillai, United States
“What Goes Around, Comes Around”: How to Be a Successful Transplantation Mentor

Jon Kobashigawa, United States
“Cry Me a River”: Making the Field of Transplantation More Attractive

07:00-08:00

10

07:00

Invited Symposia: Consequences of Pregnancy on Alloimmunity

Full Details

Anita Chong, United States
Implications of Pregnancy on Immunity

Fadi Lakkis, United States
Innate Allorecognition and Reproductive Success

Ina Stelzer, United States
Immunological Consequences of Microchimerism in Pregnancy

07:00-08:00

4

07:00

Invited Symposia: Biomarkers - Will We Ever Get Closer to Predicting Outcomes

Full Details

Jennifer Li, Australia
Pan Organ Biomarkers

Marc Raynaud, France
What Is the Next IBox?

Miguel Fribourg, United States
A Redox-based Approach for Monitoring T Cell Function in Transplant

07:00-08:00

153

07:00

Invited Symposia: Top Papers in Transplant Infectious Diseases

Full Details

Marcus Pereira, United States
Top Papers in Viral Infections

Nicolas Mueller, Switzerland
Top Papers in Bacterial Infections

C. Orla Morrissey, Australia
Top Papers in Fungal Infections

07:00-08:00

155

07:00

Invited Symposia: Innovative Tools in Transplant Education

Full Details

Sara Dong, United States
Developing a Podcast

Jeremey Walker, United States
Gamification as a Learning Tool

Candice Coghlan, Canada
Tips & Tricks for Patient Webinars

07:00-08:00

20

07:00

Invited Symposia: Challenges in the Management of Lung Transplant Recipients

Full Details

Matthew Hartwig, United States
Gastroesophageal Reflux and Management Post-lung Transplant

Erika Lease, United States
Difficult to Manage Post-lung Transplant Infections

Stephen Juvet, Canada
Alphabet Soup of Rejection Including Biomarkers: ALAD, BLAD, CLAD

07:00-08:00

25

07:00

Invited Symposia: Mortality and Cardio-Kidney-Metabolic Complications in Kidney Transplantation: The State of Evidence and the Need for Outcome Trials

Full Details

Shaifali Sandal, Canada
Cardiometabolic and Renal (CVRM) Pathways to Post-kidney Transplant Mortality

David Vock, United States
The Need For Trials - Novel Trial Endpoints

Martina McGrath, United States
SGLT2 Inhibitors in Kidney Transplantation

07:00-08:00

21

07:00

Invited Symposia: Culturally Safe Organ Donation

Full Details

gurch randhawa, United Kingdom
Cultural / Religious Barriers to Deceased and Living Donation Among Immigrant Populations

Caroline Tait, Canada
Living Donation in Indigenous Populations Around the Globe

Rudolf Garcia-Gallont, Guatemala
Living Donation in Poor Populations

Burnett Kelly, United States
Living and Deceased Donation in African Americans

07:00-08:00

23

07:00

Invited Symposia: Best Practices for Transitioning Pediatric Recipients to Adult Transplant Programs

Full Details

Anne Loes van Staa, Netherlands
Transition in Chronic Illness

Megan Kamath, United States
Challenges and Opportunities for Improvement

Anne Dipchand, Canada
Strategies for Transition

07:00-08:00

24

07:00

Invited Symposia: State-of-the-Art BK Virus

Full Details

Camille Kotton, United States
Overview of the Updated BK Guidelines

David Wojciechowski, United States
Novel Treatment Paradigms for BK Virus

Ilies Benotmane, France
Modulating Immunosuppression to Manage BK

07:00-08:00

9

07:00

Invited Symposia: New Frontiers in VCA and Uterus Transplantation

Full Details

Paige Porrett, United States
Mother and Child: Basic and Translational Research in Uterus Transplantation

Fadi Issa, United Kingdom
Spatial Transcriptomics and VCA

Jelena Janjic, United States
Can Nanotechnology revolutionize VCA

07:00-08:00

12

07:00

Rapid Fire Oral Abstract Session: Insights from Transplant Science

Full Details

Scott Krummey, United States
Dual CXCR3 and CD28 Blockade Synergistically Prolongs Graft Survival and Potently Restrains Effector CD8⁺ T Cells

Ashley Haluck-Kangas, United States
Graft-Derived Extracellular Vesicles Carry miRNAs That Promote Macrophage M1 Polarization in a Murine Allogeneic Heart Transplant Model

Olivia Fay, United States
Cytomegalovirus-Infected Dendritic Cells Demonstrate Dysregulated Insulin-Like Growth Factor Signaling Associated with Loss of T Cell Anergy

Jasmine Shwetar, United States
Heterogeneous B Cell Subsets Clonally Expand in Human Lymph Nodes under Immunosuppression

Kohei Kinoshita, United States
Graft Survival and Rejection Risk with TNX-1500 as Monotherapy or in Combination with Conventional IS Agents in Nonhuman Primate Heart Transplants

James Keiler, United States
Adjuvant IL15 Blockade Significantly Improves Survival When Combined with a Costimulation-Based Immunosuppression Protocol of Pig-to-Nonhuman Primate Renal Xenotransplantation

James Keiler, United States
Targeting CD11b - An Alternative Binding Site of CD154 - Increases the Prevalence of Exhausted TEMRA CD8 T Cells in a Nonhuman Primate Model of Renal Allotransplantation

Kohei Kinoshita, United States
Dual Blockade of CD154 and CD28 Co-Stimulation Pathways Mitigates Pathogenic Allo-Immunity and Enhances Survival in Cynomolgus Cardiac Transplantation

07:00-08:00

8

07:00

Rapid Fire Oral Abstract Session: Deceased Donor Kidney Access to Waitlist/Transplant Outcomes

Full Details

Amy Waterman, United States
Identifying Quality Improvement Opportunities to Increase Early Transplant Preparation and Pursuit of Transplant

Sobhana Thangaraju, Singapore
National Trends of Sex Disparity over 5 Decades of Living Donor Kidney Transplantation in Singapore

Fawaz Al Ammary, United States
Association Between California Kidney Transplant Waitlist and Living Donor Kidney Transplantation

Anil Paramesh, United States
From Bias to Balance: The Role of Race-Neutral eGFR in African American Transplant Equity

Tennille Vitagliano, Australia
Intersectional Disadvantage and It's Effect on Living Donor Kidney Transplant Access in Australia: A National Cohort Study (2006-2023)

Lung-Yi Lee, United States
Disparities in Kidney Transplantation Access and Outcomes Among Native Hawaiians and Pacific Islanders in the United States

John Holland, United Kingdom
Comprehensive Geriatric Assessment (CGA) and Optimisation Services Prior to Kidney Transplantation in Older Potential Recipients: Results from the First UK-Wide Transplant Centre and Renal Unit Survey Study

Stuart Knechtle, United States
Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation: Preliminary Results of the ADAPT Trial

07:00-08:00

11

07:00

Invited Symposia: Why Are Islet Cell Transplants Failing in the US and Thriving in the Rest of the World?

Full Details

Piotr Witkowski, United States
Challenges in the US Leading To the Demise of Islet Allotx

Trevor Reichman, Canada
Pancreatic Islet Transplant: A Viable Alternative to Pancreas Transplantation

07:00-08:00

154

07:00

Late-Breaking Oral Abstract: Non Immunological Outcomes

Full Details

Anthony Langone, United States
Cognitive Outcomes and Quality of Life in Stable Renal Transplant Patients Switched from Twice-Daily Tacrolimus to Envarsus XR^TM

BEATRIZ RODRIGUEZ-CUBILLO, Spain
Impact of a Multidisciplinary, Holistic Clinic on Kidney-Transplant Recipients with Complex Needs: Twelve-Month Prospective Evaluation

BEATRIZ RODRIGUEZ-CUBILLO, Spain
Clinical and Symptom Profile of Kidney Transplant Recipients Flagged by the NECPAL Tool: Cross-Sectional Analysis from a Multidisciplinary Clinic

Elias David Neto, Brazil
The Effect of Adding Dapagliflozin on Chronic Allograft Dysfunction. A Prospective, Randomized, Double-Blind, Placebo-Control Trial

Hee Jung Jeon, Korea
Association of Post-Transplant Apolipoprotein A-1 Levels with Cardiovascular Events and Graft Loss in Kidney Transplant Recipients: Results from the KOTRY Study

08:15-09:30

20

08:15

Invited Symposia: Psychosocial Issues in Living Donation

Full Details

AnnMarie Liapakis, United States
The Overwhelmed Donor

Peter Reese, United States
Care of the Denied Donor

Martina McGrath, United States
The Psychosocial Risks and Benefits of Living Donation

Filza Hussain, United States
Substance Use in Living Donors

08:15-09:30

8

08:15

Invited Symposia: Challenging Cases World Edition: Transplant ID Experiences Across the Globe

Full Details

Marian Michaels, United States
Panelist

Thuan Tong Tan, Singapore
Panelist

Sara Belga, Canada
Panelist

Ligia Pierrotti, Brazil
Panelists

Ajit Limaye, United States
Panelists

08:15-09:30

21

08:15

Invited Symposia: Advanced Practice Providers on the Cutting Edge: Expanding Roles in Surgery and Transplant Research

Full Details

Erin Kinsella, United States
APP-Led Robotics: APPs in Robotic and Minimally Invasive Donor Surgery

Carlee Komoroski, United States
Lifeline Logistics: APPs on the Frontlines of Organ Procurement

Kelly Cederquist, United States
Into the Future: APPs in Research

Georgeine Smith, United States
Guardians of Viability: APPs in Organ Perfusion and Preservation

08:15-09:30

12

08:15

Invited Symposia: Pediatric Access to Transplantation

Full Details

Jennifer Vittorio, United States
Overview of Global Pediatric Access to Transplantation

Julie Ingelfinger, United States
Dare to Dream - A World Where Every Child in Need Receives a Transplant!

Sajid Sultan, Pakistan
Role of Philanthropy

Emily Perito, United States
How to Increase Deceased Donor Organ Availability for Pediatric Recipients

08:15-09:30

155

08:15

Invited Symposia: Innovation in Organ Allocation

Full Details

James Lan, Canada
Eplet Matching - Is It Feasible and Equitable?

Deirdre Sawinski, United States
Preemptive Transplantation

Betsy Verna, United States
Moving Away From Transplanting the Sickest Patients in Liver Transplantation

Jon Snyder, United States
Continuous Distribution

Elizabeth Pomfret, United States
Longevity Matching Revisited

08:15-09:30

10

08:15

Invited Symposia: Transplantation in the Context of Migration and Refugees: An Update of the DICG and TTS Ethics Committee Workshop TTS 2022

Full Details

Toby Coates, Australia
Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Australia / Refugees From SE Asia, Pacific Islands)

Jolanta Malyszko, Poland
Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Poland / Refugees-Migrants From Ukraine)

Alejandro Murcia, Colombia
Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (Colombia / Refugees-Migrants From Venezuela)

Peter Stock, United States
Brief Updates on Report of the DICG/TTS Ethics Committee Workshop From Buenos Aires 2022 Meeting (USA / Refugees-Migrants Non US Citizens to USA)

Frederike Ambagtsheer, Netherlands
Ethical and Legal Challenges Impacting Refugees and Migrants With ESRD - The Need for International Attention

Rumeyza Kazancioglu, Turkey
Access to Dialysis/Transplantation for Syrian Refugees in Türkiye

Mekdim Tadesse Siyoum, Ethiopia
Transplantation in Ethiopia - The Impact of Internal Conflict

08:15-09:30

154

08:15

Invited Symposia: Donor Follow Up – How Can We Do Better?

Full Details

Ngan Lam, Canada
The Global Status of Post-Donation Follow-Up

Ajay Israni, United States
Efforts to Establish Follow Up in the US

Sunita Singh, Canada
What Do Donors Want?

Emilio Poggio, United States
Engaging Donors in Health Maintenance Post Donation

Hajeong Lee, Korea
Living Donor Registry: The South Korean Experience

08:15-09:30

23

08:15

Invited Symposia: Quality and Value in Organ Donation and Transplantation

Full Details

Rutger Ploeg, United Kingdom
Quality in Organ Donation Services

Greg Knoll, Canada
Quality in Kidney Transplantation

Brooke Iarkowski, United States
Quality From the Donor's Perspective: A Past Living Donor's Perspective

Alexandra Glazier, United States
You Know It When You See It - The Elusive Concepts of Quality and Value in Healthcare

Kevin Longino, United States
Measures of What Matters to Patients

08:15-09:30

153

08:15

Invited Symposia: Ethics and Legal Considerations in Deceased Donation

Full Details

Maryl Johnson, United States
Deceased Donor Intervention Research

Sanjay Nagral, India
Donor Rewards and Recognition: International Perspective

Kim Wiebe, Canada
Deceased Donation After Medical Assistance in Dying

Anji Wall, United States
Ethics of Normothermic Regional Perfusion

08:15-09:30

24

08:15

Invited Symposia: From "Good Enough" to "Great": Addressing Barriers to Improving Immunosuppression

Full Details

Nithya Santhana Krishnan, United Kingdom
The (Unspoken) Risks of Over-Immunosuppression

Stefan Schneeberger, Austria
Regulatory Pathways and Barriers to Innovation: Lessons from the EMA

Ulf Meier-Kriesche, United States
Industry Partners: Friends or Foes?

Dirk Kuypers, Belgium
Can Technology and Therapeutic Monitoring Strategies Improve the Gap?

Michael Collins, Australia
Structuring Trials of Novel Agents: Risks and Opportunities

08:15-09:30

4

08:15

Invited Symposia: Innovations in Organ Preservation and Perfusion Strategies

Full Details

Peter Abt, United States
The Evidence for in Situ Versus Ex Situ Perfusion of DCD Donor Organs

David Axelrod, United States
Economic Considerations of Implementing Perfusion Technology: Can We Afford It?

Erik Finger, United States
Cryopreservation, Vitrification, and Nano-Rewarming: The Next Innovation in Organ

ROBERT Porte, Netherlands
Advancements in Combined Hypothermic and Normothermic Machine Perfusion: Controlled Oxygenated Rewarming

08:15-09:30

22

08:15

Invited Symposia: Harnessing Social Media for Good

Full Details

Juliet Emamaullee, United States
Creating a Social Profile to Advance Your Science: Pearls and Pitfalls

SUNIL SHROFF, India
Using Social Media to Increase Organ Donation Awareness and Support

Macey Levan, United States
Using Social Media to Find a Donor

Richard Hasz, United States
Spreading the Gospel of Transplant to the Public

08:15-09:30

9

08:15

Oral Abstract: VCA

Full Details

YINAN GUO, United States
Myd88-Areg Axis in Regulating Host Responses to Vascularized Composite Allotransplantation

Bruce Gelb, United States
Post-Transplant Malignancy Following Vascularized Composite Allotransplantation

Jelena Janjic, United States
A First-in-Class Imaging Capable Acellular Oxygen Nanocarrier Perfusate for Extended Machine Preservation of Organs

Paige Porrett, United States
Spectrum of Pregnancy Complications Induced by Tacrolimus

Daniel Brennan, United States
Donor-Derived Cell-Free DNA (dd-cfDNA) in Vascularized Composite Allograft Recipients

Elizabeth Stearns, United States
Optimizing VCA Donors: Transplant Center Perspective

William Crisler, United States
Sentinel Flaps Reflect Inflammation and Rejection in Human Face Allografts

Nima Nassiri, United States
First-In-Human Bladder Transplant

08:15-09:30

25

08:15

Invited Symposia: Costimulation - from Biology to Clinical Trials

Full Details

David Hildeman, United States
Single Cell Analysis of Rejection under Costimulation Blockade

Mandy Ford, United States
Fgl2/Fcgr2b - The New Kid on the Block

Allan Kirk, United States
Blocking CD40/CD40L in Allo and Xenotransplantation

Gilles Blancho, France
FIRsT - Anti-CD28 Fabs in humans (Phase 1/2 study)

08:15-09:30

11

08:15

Late-Breaking Oral Abstract: Liver Transplantation: New Techniques, Immunosuppression Strategies and Patient Outcomes

Full Details

Kishore Iyer, United States
The Bypass Paradox - Frequency and Impact of UNOS Bypass Code 850 on ‘Out of Sequence’ liver Allocation

Erin Duggan, United States
A Stepwise Institutional Progression to Total Robotic Liver Transplantation: Technical Refinements into a Simpler and Reproducible Technique Across Eight Cases

Pranit Chotai
Trends and Recipient Outcomes in Liver Transplants from Hepatitis C Donors: A National Analysis by Donor Age

Yuzuru Sambommatsu, United States
Total Robotic Living Donor Liver Transplantation: First North American Case

Marco Maria Pascale, Italy
Immunomodulation through Hypothermic Oxygenated Perfusion in Liver Transplantation: Biomarker Analysis in Peripheral Blood

Ilya Kantsedikas, United Kingdom
Living Liver Donor Intra-operative Analgesia and Day 1 Pain - Insights from the International LDLT Registry

Michelle Callegari, United States
Health-Related Quality of Life Improves Rapidly after Liver Transplantation - Findings from the PRO-LT Study

10:00-10:30

Plenary

10:00

Stem Cell Derived Beta Cell Clusters and Successful Allotransplantation - Hongkui Deng

Full Details

Hongkui Deng, People's Republic of China
Stem Cell Derived Beta Cell Clusters and Successful Allotransplantation

10:30-11:30

Plenary

10:30

Plenary: Plenary Abstracts 3

Full Details

Dirk Kuypers, Belgium
Integrated Model-Informed Precision Dosing (MIPD) of Tacrolimus in Organ Transplantation

Khodor Abou-Daya, United States
Ly6-C^hiCD56⁺ Stem-Like Monocytes Propagate Specific Innate Immune Memory

Fei-Man Hsu, United States
First-Year Post-Transplant Respiratory DNA Methylation Profile Predicts Chronic Lung Allograft Dysfunction

Thiago J. Borges, United States
High-Resolution Profiling of Immune Responses Following Gene-Edited Pig Kidney Xenotransplantation

11:30-12:45

Plenary

11:30

Presidential Addresses: TTS Presidential Address & Society Awards

Full Details

Peter Stock, United States
Introduction of John Fung

John Fung, United States
Presidential Address

Maria Matamoros, Costa Rica
DICG Updates

John Fung, United States
Introduction of TTS Journals EiC

Stefan Tullius, United States
TTS Journals - EiC Highlghts

John Fung, United States
Brent & Monaco Awards

John Fung, United States
Introduction of Sanjeev Kanoria Awards Program

Nadey Hakim, United Kingdom
Introduction of Sanjeev Kanoria

Sanjeev Kanoria, United Kingdom
Speaker

John Fung, United States
Closing & invitation to TTS 2026

12:15-15:30

154

12:15

Invited Symposia: Global Perspectives on Genetic Insights for Optimizing Transplant Success

Full Details

Madhav Menon, United States
Non-HLA Genetic Factors in Recipient and Donor Compatibility

Dirk Kuypers, Belgium
Complex Genetic Conditions, Pharmacogenomics and Polygenic Risk Scores in Kidney Transplantation: A Global Approach

Yasar Caliskan, United States
Clinical Use of Genetic Testing for Monogenic Diseases in Transplant Recipients: Regional Applications

Francesca Zanoni, Italy
Clinical Use of Genetic Testing for Monogenic Diseases in Transplant Recipients: Regional Applications

12:15-15:30

25

12:15

Invited Symposia: Xenotransplantation - Clinical Achievements and Next Steps

Full Details

Wayne Hawthorne, Australia
History and Current Status of the Field

Winfred Williams, United States
The Right Patient

Alfred Tector, United States
The Right Pig

Alfred Tector, United States
The Right Immunosuppression

12:15-15:30

23

12:15

Invited Symposia: Novel Diagnostics in Transplant Infectious Diseases. Some Hope or Just Nope?

Full Details

Kimberly Hanson, United States
Microbial cfDNA: Ready for Universal Use (CON)

Monica Fung, United States
Microbial cfDNA: Ready for Universal Use (PRO)

John W. Baddley, United States
Does Galactomannan Change Your Management? (PRO)

Sophia Koo, United States
Does Galactomannan Change Your Management? (CON)

12:15-15:30

11

12:15

Invited Symposia: Navigating the Future: Implementation of Patient Navigation Strategies in Organ Transplant Across the Globe

Full Details

Nicole Scholes-Robertson, Australia
Rural & Remote Access to Healthcare for Patients With Chronic Kidney Disease

Tanjala Purnell, United States
Equity in Access to Kidney Transplantation

WTC 2025, Singapore
Panel Discussion

12:15-15:30

10

12:15

Invited Symposia: Pregnancy in Transplant Recipients: From Preconception to Birth

Full Details

Silvi Shah, United States
Preconception Counseling

Nicole Alvey, United States
Medication Safety During Pregnancy and Breastfeeding

Monika Sarkar, United States
Contraception

Margriet de Jong, Netherlands
Lessons Learned From Pregnancy Registries Worldwide

12:15-15:30

155

12:15

Invited Symposia: Addressing Disparities in Access to Transplantation

Full Details

Lisa McElroy, United States
Social Determinants of Health - Measures and Interventions

Sixto Giusti, United States
Undocumented Persons

Elizabeth Hendren, Canada
Gender Disparities - Global Perspective

Teri Browne, United States
Community Engagement Strategies

Leigh Anne Dageforde, United States
Health Literacy

12:15-15:30

8

12:15

Invited Symposia: Wait-List Access and Management

Full Details

Jesse Schold, United States
Mandatory Referral to the Wait-List

Tracey Ying, Australia
Screening for CAD

Germaine Wong, Australia
Waitlisting the Patient with Cancer

Joel Adler, United States
Patient Representation on Wl Selection Committees

Adnan Sharif, United Kingdom
Should There Be a Standard Approach to Removing Patients from the Waiting List

12:15-15:30

22

12:15

Invited Symposia: Non-HCC Liver Malignancy and Transplantation: Evolving Patient Selection Criteria, Graft Preservation Methods, and Post-transplant Outcomes

Full Details

Dong-Sik Kim, Korea
Unresectable Colorectal Liver Metastases: Updates in Recipient Selection, Surgical Techniques and Post-transplant Outcomes

Keri Lunsford, United States
Advancements in Transplant Oncology for Cholangiocarcinoma

Laia Aceitunosierra, Canada
Biomarkers Predictive of Recurrent Liver Tumors

Andrea Schlegel, United States
Impact of Donor Characteristics and Graft Preservation Methods on Post-transplant Outcomes

12:15-15:30

4

12:15

Invited Symposia: Artificial Intelligence in Transplantation: From Theory to Practice

Full Details

Jean Yang, Australia
Multi-Omics Integration in Transplantation

Alexandre Loupy, France
Integrating Artificial Intelligence into Clinical Decision Making: Promise of a Virtual Biopsy

Mohammed Akhtar, United States
AI: Present and Future: Potential for Solid Organ Transplantation

Nikki Marks, Canada
Role of Generative AI in Transplant Medicine

12:15-15:15

9

12:15

Invited Symposia: Updates from STAR

Full Details

Chris Wiebe, Canada
Updates in the Analytic and Clinical Validity of Non-HLA DSA Testing

Marlena Habal, United States
Practical Use of Titers to Measure HLA Antibody Reduction

Kelley Hitchman, United States
Donor Derived Cell Free DNA: The Path to Clinical Utility

12:15-15:15

24

12:15

Invited Symposia: 70th Anniversary of the First Successful LD Kidney Transplant

Full Details

Lloyd Ratner, United States
Surgical Advances Over Time

Robert Montgomery, United States
The Incompatibility Challenge : From Identical Twins to Kidney Paired Donation

Arthur Matas, United States
Evolution of the Understanding of Donor Risk

J. Harold Helderman, United States
Remembering the First Kidney Transplant

Denice Lombard, United States
The Longest Surviving Living Donor Transplant Recipient

Jamil Azzi, United States
The First Transplant in Pictures

12:15-15:15

20

12:15

Invited Symposia: New Drugs in Pediatric Transplantation

Full Details

Marc Foca, United States
Antivirals

Carissa Baker-Smith, United States
Glp-1

Rouba Garro, United States
Sglt-2

12:15-15:30

21

12:15

Oral Abstract: Global Trends in Donor-Derived Infections

Full Details

Helen Te, United States
Donor-Derived Hepatitis B Virus (HBV) Infection in Solid Organ Transplant (SOT) Recipients: Report from the Organ Procurement & Transplantation Network Ad Hoc Disease Transmission Advisory Committee (OPTN DTAC)

Ines Ushiro-Lumb, United Kingdom
Lessons from a Newly Implemented Organ Donor Screening for Human Herpes Virus Type 8 in the UK

José Pestana, Brazil
Impact of Dengue Outbreak on Solid Organ Transplant Programs in an Endemic Region: Devising and Implementation of Risk Mitigation Strategies

Dzhuliyana Handarova, United States
Trends in Deceased Donor 2020 Public Health Service Guideline Risk Criteria

Klaus Böhler, Germany
Donor-Derived Infections in Deceased Donor Organ Transplantation in Germany from 2016-2024

Stephanie Pouch, United States
Donor-Derived Transmissions 2023: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

Olivia Smibert, Australia
Burden of Infectious Diseases in Potential Organ Donors in Victoria, a Retrospective Audit of All Potential Organ Donors Between 2014-2024

Oscar Fernandez Garcia, Canada
Trends in Deceased Organ Donor Risk Factors for Bloodborne Infections. A Single-Centre Retrospective Study

12:15-15:30

153

12:15

Oral Abstract: Deceased Donor Kidney Allocation 2

Full Details

David Walls, United States
Out-of-Sequence Kidney Allocation: Identifying a Subgroup with Superior Outcomes

David Walls, United States
Out-of-Sequence Allocation Allows Increased Utilization of Kidneys While Providing Equivalent Outcomes to Standard Allocation Kidney Transplants

Keighly Bradbrook, United States
Deceased Donor Kidneys Allocated out of Sequence Differ from Kidneys Allocated in Sequence - Do Outcomes Differ?

Douglas Keith, United States
The Current Iteration of Zero HLA Mismatch Priority in KAS is Highly Biased Against Minorities, Shunts Kidneys Away from Blood Type O Recipients, and Has a Marginal Impact on Graft and Patient Outcomes

Keith McCullough, United States
HLA Class I Amino Acid Mismatches That Distinguish Divergent HLA-A Allele Lineages Confer Incremental Risk of Kidney Allograft Failure Independent of Class II Mismatches

David Leeser, United States
Improving the Fit: Adding County Deprivation Index to SRTR Graft Outcomes

Benjamin Bizer, United States
Kidney Donation: Public Engagement and Readability of Online Resources - An AI-Driven Sentiment and Content Analysis

12:15-15:30

12

12:15

Oral Abstract: Kidney Biomarkers, Imaging, and Engineering

Full Details

Marta Sablik, France
Association of Donor-Derived Cell-Free DNA with Microvascular Inflammation Phenotypes in Kidney Allografts

John Fallon, United Kingdom
Characterising Prognostic Complement Biomarkers during Clinical Normothermic Machine Perfusion for Renal Transplantation

Romain Brousse, France
Performance of Integrative dd-cfDNA in Detecting Rejection Based on the Updated Banff 2022 Classification

Akhil Singla, United States
Using Torque Teno Virus as a Serial Monitoring Tool Representing the Net State of Immunosuppression for Kidney Recipients

Chethan Ashokkumar, United States
A Multiclass Machine Learning Model with Allospecific B-Cells and T-Cells Predicts Antibody- and T-Cell-Mediated Rejection (ABMR, TCMR) After Kidney Transplantation (KT)

Chirag Parikh, United States
Improving the Prediction of Deceased Donor Allograft Function with Donor Urinary Biomarkers

Elena Crespo, Spain
Longitudinal Assessment of Alloreactive Memory T and B Cells in the EUTRAIN Kidney Transplant Cohort

Anil Bhalla, India
Early Post-Transplant TTV Load: A Biomarker of Immunosuppression and Infection

16:30-17:45

10

16:30

Oral Abstract: Immunomodulation

Full Details

Abraham Matar, United States
A Novel Anti-CD154 Nonantibody Fusion Protein Facilitates Long Term Pig to Primate Kidney Xenograft Survival

Tatsuo Kawai, United States
Multiple Human Transgenes Prolong Survival of Triple-Carbohydrate Knockout Porcine Kidney Xenografts in Nonhuman Primates

Chao Yang, People's Republic of China
NR4A1 Drives Immunoregulatory Macrophage Development to Protect Renal Allografts by Restraining Tissue-Resident Memory T Cell Activity

Sayantan Bose, United States
Immunoevasion by Intragraft Semaphorin 3F Following Transplantation

Madonna Anggelia, Taiwan
Targeting HIF-1α and miR-17-92 in CD4⁺ T Cells to Improve Vascularized Composite Allotransplantation Outcomes

YUKI MARUYAMA, United States
Absence of Recipient NKG2D or Allograft Donor Rae-1 Abrogates Acute Antibody-Mediated Rejection of Kidney Allografts in a Novel Mouse Mode

Jean Kwun, United States
Immunoproteasome Inhibitor (KZR-616) Desensitization and Maintenance Therapy in Highly Sensitized Non-Human Primates

Kassandra Baron, United States
Allogeneic Reparative Treg Cell Therapy Augments Local Reparative Macrophages and Promotes Tissue Repair After Lung Injury

16:30-17:45

12

16:30

Oral Abstract: From Pre-Clinical Studies to First in Human: What's New on the Horizon

Full Details

Masaki Komatsu, United States
Adaptive Responses within the Graft Endothelial Cell as a Determinant of Long-Term Survival

Hengcheng Zhang, United States
Intrarenal T Follicular Helper Cells Promote Alloimmune Injury and Fibrosis After Kidney Transplantation

Leonardo Riella, United States
First and Second Genetically Modified Pig Kidney Xenotransplants in Living Human Recipients: Immunological and Physiological Insights

Kenneth Brayman, United States
IL-13: A New Ally in the Fight for Islet Graft Survival

Wayne Hancock, United States
Five Strategies to Use IL-2 Muteins to Expand Foxp3+ Treg Cells and Promote Long-Term Cardiac and Renal Allograft Survival in Naïve and Sensitized Recipients

Daniel Calabrese, United States
Novel Anti-CD94 Treatment Reduces Kidney Ischemia-Reperfusion Injury and Subsequent Acute Lung Injury

Bayan Alsairafi, United States
Effects of Targeting the Cullin RING E3 Ubiquitin Ligase Using MLN4924 on the Alloimmune Response

Jean Kwun, United States
An IL-2 Mutein (VIS171) Induces Regulatory T Cells and Prolongs Survival in a Rhesus Kidney Transplant Model

16:30-17:45

8

16:30

Oral Abstract: Lifelong Viral Invaders in Transplant

Full Details

Mayyadah Alabdely, United States
Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single-Center Experience

Edward Vizcarra, United States
T Cell Profiling Reveals Functional Immune Defects in Pediatric Transplant Recipients with Chronic Epstein-Barr Virus DNAemia

Avery Koi, United States
From Incurable to Successful Transplantation: Long Term Outcomes in HIV+ vs HIV- Liver Transplant Recipients at 1, 3, and 5 Years - A Retrospective Analysis

Daniel Dulek, United States
Multicenter Prospective Cohort Study of CMV T Cell Immunity and First Post-Transplant CMV DNAemia in Pediatric Solid Organ Transplant Recipients

Bailey Conkey, United States
Clinical Significance of Persistent Low-Level CMV DNAemia in Solid Organ Transplantation

Mingqian Feng, People's Republic of China
A Novel gp350/CD89-Targeted Bispecific Antibody Against Epstein-Barr Virus (EBV) Infection and EBV-Associated Hematological Diseases

Deepali Kumar, Canada
Disseminated Varicella-Zoster Virus Infection in Transplant Recipients: A 10-Year Review

Kapil Saharia, United States
Risk of De Novo Hepatitis B Infection in HBsAg- Recipients of HBcAb+/HBsAg- Liver Grafts Who Discontinue Antiviral Prophylaxis

16:30-17:45

153

16:30

Oral Abstract: Grafts and Germs: Infectious Challenges in Transplant Medicine

Full Details

NITHYE PARVATHY, India
Shifting Trends in Terminal Infections of Post Renal Transplant Recipients: Insights from an Autopsy Study

Lucas Garcias, Argentina
Preservation Fluid Cultures in Simultaneous Pancreas and Kidney Transplantation. Twenty Years of Experience

Joanna Schaenman, United States
Frailty by Chart Review Can Predict Infection in Kidney Transplant Recipients: A Multicenter Study through the AST IDCOP

Laura Donadeu Casassas, Spain
T-Cell Exhaustion Impacts Specific Adaptive Responses After Vaccination in Solid Organ Transplant

Gang Huang, People's Republic of China
Single-Cell RNA Sequencing Reveals the Immune Microenvironment of BK Polyomavirus Nephropathy

Kapil Saharia, United States
Hepatitis B Vaccine Compliance and Seroresponse Rates Among Solid Organ Transplant Recipients Receiving Recombinant versus Adjuvanted HBV Vaccine

Anthony Langone, United States
Stool Studies in Kidney Transplant Recipients: A Single-Center Retrospective Review of 1,000 Cases

Daniela Barisano, United States
Influenza Vaccine Effectiveness and Disease Burden in Children and Adolescents with Solid Organ Transplant: 2018-2024

16:30-17:45

20

16:30

Oral Abstract: The Future of Heart Transplant Surveillance?

Full Details

Philip Halloran, Canada
Defining Relationships Among Tests for Heart Transplant Antibody-Mediated Rejection

Jon Kobashigawa, United States
High Level Donor Derived Cell-Free DNA in Asymptomatic Patients After Heart Transplant - Does It Matter?

Kris Oreschak, United States
Prognostic Value of Donor-Derived Cell-Free DNA in Combination with HLA1 and HLA2 Donor Specific Antibodies After Heart Transplant

Kris Oreschak, United States
Leveraging Longitudinal Donor-Derived Cell-Free DNA and Gene Expression Profiling Data for Acute Cellular Rejection Diagnosis After Heart Transplant

Kris Oreschak, United States
Antibody Mediated Rejection in the Contemporary Donor-Derived Cell-Free DNA Era: An Analysis of the Surveillance HeartCare Outcomes Registry

Kris Oreschak, United States
Impact of Persistently Elevated Simultaneous Gene Expression Profiling and Donor-Derived Cell-Free DNA on Future Clinical Events

Alessia Giarraputo, France
Molecular Classification System for Cardiac Allograft Rejection is Positively Associated with the Pathology Severity of Rejection

Stephanie Golob, United States
Association of ImmuKnow with Post-Transplant Coronary Artery Vasculopathy

16:30-17:45

9

16:30

Oral Abstract: Pharmacotherapy and Adherence

Full Details

Mark Wakefield, United States
The SystemCHANGE^TM Intervention Improves Medication-Taking Habit: A Secondary Analysis of the MAGIC Studies

Lidan Gu, United States
The Characteristics of Early Medication Level Variability in Pediatric Kidney Transplant Recipients

Sunjae Bae, United States
Evidence-Based Individualization of Early Steroid Withdrawal and Its Association with Mortality After Kidney Transplantation

Nicole Wilson, United States
Predicting Unbound Tacrolimus Concentrations during Pregnancy

Ann Kataria, United States
Utilizing EHR-Integrated Proportion of Days Covered (PDC) to Monitor Post Kidney Transplant Medication Adherence

Kelsey Coffman, United States
More Than Numbers: Predictors of Success in Belatacept Conversion in Kidney Transplant Recipients

Christine Wolesensky, United States
Improved Tacrolimus XR Dosing and Monitoring Outcomes with a Genotype-Based Dosing Algorithm vs. Weight Based Dosing

Jiqiu Wen, People's Republic of China
Telitacicept Treatment for Active Antibody-Mediated Rejection: Case Series Report

16:30-17:45

22

16:30

Oral Abstract: Education

Full Details

Jennifer Wainright, United States
Characteristics Associated with Acceptance of Porcine Xenotransplantation

Cory Schaffhausen, United States
The Impact of Transplant Metric Visual Icons on Patient Decisions to Select a Transplant Center

Jesse Schold, United States
Censoring Scientific Dissemination in Transplantation

Akshta Pai, United States
Bridging the Gap: Assessing Knowledge, Preparedness, and Regulatory Perspectives on Genetically Engineered Pig-to-Human Xenotransplants Among Transplant Specialists

Gina Jamero, United States
Advanced Practice Provider Transplant Certification - Results of a Needs Assessment Survey

Saad Hussain, United States
Bridging the Gap: A Comprehensive Summer Student Immersion Program in Transplantation

Bradon Nave, United States
Research Exclusive Donation: Revolutionizing Medical Research through Organ Procurement Organizations

Kiran Goli, United States
Innovative AI-Driven Transplant Board Review Series: Enhancing Fellow Engagement and Learning in Nephrology Fellowship Training

16:30-17:45

154

16:30

Oral Abstract: Expanding the Donor Pool

Full Details

Chase Wehrle, United States
Cost Effectiveness Analysis and Clinical Outcomes of Back-to-Base Normothermic Machine Perfusion with and without FMN: A Multi-Center Risk-Matched Study of 967 Patients

Kliment Bozhilov, United States
A UNOS Database Outcomes Analysis of DCD Liver Transplantation Using Sequential Normothermic Regional Perfusion and Normothermic Machine Perfusion versus NRP Alone

Alexander Cortez, United States
Impact of Normothermic Machine Perfusion on Liver Transplant Outcomes: A Multi-Institutional Experience from the National Organ Perfusion Registry

Haseeb Zubair, United States
Molecular Differences in Injured Cholangiocytes during Cold Static Storage of Livers from Standard and Extended Criteria Donors

CHUNBAO JIAO, United States
Optimizing Donation After Circulatory Death (DCD) Liver Preservation with Resveratrol during Machine Perfusion

Anji Wall, United States
NRP DCD Liver Grafts Yield Equal Outcomes of DBD Liver Grafts: A Single US Center Experience

David Axelrod, United States
Economic Assessment of Hypothermic Oxygenated Machine Perfusion in Liver Transplantation

Anji Wall, United States
The Impact of a Transplant-Center Based Normothermic Regional Perfusion Program on Liver Transplant Volume and Finances

16:30-17:45

155

16:30

Oral Abstract: Liver Malignancies

Full Details

Yuki Imaoka, Japan
IL-37 Enhances Immunotherapeutic Potential of Off-the-Shelf Liver NK Cells for Hepatocellular Carcinoma: Overcoming Cryopreservation Challenges

Sabrina Leo, Canada
Retinoid Acid Receptor-Related Orphan Receptor Gamma (RORγ): A Potential Target in Transplantation Oncology to Expand Therapeutic Options for Patients with Hepatocellular Carcinoma (HCC)

Zijie Zhang, People's Republic of China
Integrative Multi-Omics Analysis Identifies Evolving Landscape and Potential Targets for Recurrent HCC After Liver Transplant

Allison Kwong, United States
Fewer Liver Transplant Recipients with HCC Are Waiting ≥6 Months for Transplant in the United States

Jin-Chiao Lee, Taiwan
Risk Stratification Based on Non-Transplantable Recurrence for Treatment Allocation in Child-Pugh A Patients with Hepatocellular Carcinoma

Jiyoung Kim, Korea
Post-Transplant Malignancy Risk in Liver Transplantation Recipients: A Nationwide Matched Cohort Study Comparing Liver Cancer and Non-Cancer Recipients with the General Population

Matthew Byrne, United States
Tumor Biology-Driven Recipient Selection Determines Outcomes in Liver Transplantation for Colorectal Liver Metastases

16:30-17:45

4

16:30

Oral Abstract: Deceased Donor Kidney Procurement, Preservation, and Organ Manipulation

Full Details

Matthew Holzner, United States
Rescuing Hard-to-Place Kidneys Using a Normothermic Machine Perfusion Service: Results of the OPTIMAL Study

Yuki Bekki, United States
The Impact of Normothermic Regional Perfusion on the Utilization and Post-Transplant Outcomes for Kidney Transplantation

Samy Riad, United States
Evaluating the Impact of Machine Perfusion on Primary Nonfunction Rates in Deceased Donor Kidneys with Discarded Contralateral Mate

Tom Darius, Belgium
National Implementation of HMP Increases Local Kidney Utilisation Rate and is Highly Cost-Effectiveness

Nicholas Blount, United States
When Good Kidneys Pump Poorly: Why Some High-Resistance Organs Deserve a Chance

Sue Fu, United States
Effects of Sequential Hypothermic Machine Perfusion After Normothermic Regional Perfusion and Donation After Circulatory Death on Kidney Transplant Outcomes

Jennifer Philip, United States
Novel Perfusion Parameters Predict Early and Late Renal Allograft Outcomes

Marlene Pühringer-Sturmayr, Austria
Automated Multi-Sensor Kidney Perfusion Device Enables 5-Day Normothermic Preservation of Human and Porcine Kidneys

16:30-17:45

24

16:30

Oral Abstract: Kidney Immunosuppression Maintenance; Tolerance

Full Details

Christian Larsen, United States
Selective Implementation of Belatacept Every Other Month as Standard Care Option with Use of cfDNA Testing

Alex Rogers, United States
A Donor Derived Cell Free DNA Approach to Immunosuppression Minimization in Elderly Kidney Transplant Recipients

Elizabeth Hendren, Canada
A Matched Cohort Analysis of Kidney Transplant Recipients Treated with Depleting and Non-Depleting Antibody Induction and Early Corticosteroid Cessation

Marta Crespo, Spain
Pretransplant Response to Immunosuppressants Measured with Immunobiogram Predicts First-Year Rejection in Kidney Transplant Recipients

Alex Zendel, United States
De Novo Belatacept Maintenance Immunosuppression Protocol as a Strategy to Increase Utilization of Kidney Allografts - 5-Year Experience

Zahraa Khan, United States
HLA-Epitope Mismatches and De Novo Donor Specific Antibodies (dDSA) Development Post-BK Virus Nephropathy

Guillaume Onyeaghala, United States
Gut Microbiome Meta-Transcriptomics Associated with Mycophenolate Mofetil Enterohepatic Recirculation in Kidney Transplant Recipients

Daniel Schuster, United States
Subcutaneous Administration of a CD28 Co-Stimulation Blocker Demonstrates Efficacy in an NHP Model of Kidney Allotransplantation

16:30-17:45

25

16:30

Oral Abstract: Living Donor Kidney Selection

Full Details

Badi Rawashdeh, United States
Comparative Outcomes Analysis of Living Kidney Donors With and Without of Kidney Stones: A Propensity-Matched Study

Karny Ilan, Israel
Exploring Why Potential Living Kidney Donor Candidates Fail to Complete the Donation Process: A Comparison Between Related and Unrelated Donors

Taiki Ogasa, Japan
Application of CT Imaging Analysis Technology in Kidney Transplantation

Luke Shen, United States
Obese Living Kidney Donors - Weighing the Weight on Donors and Recipients Outcomes

Hannah Kek, Singapore
Comparative Analysis of Computerised Tomography Volumetry vs. Nuclear Imaging (Dimercaptosuccinic Acid) Scan in Predicting Early Post-Donation Renal Function Using Split Renal Function

Momoko Akasaki, Japan
Donor-Derived Nephritis on Pretransplant Biopsy Does Not Impair Posttransplant Renal Function in Recipients or Donors

Elizabeth Hendren, Canada
The Absence of Sex Related Differences in Pre-Donation eGFR Indicate a Need for Standardization of Living Donor Selection Criteria

Eoghan White, Canada
Older Living Kidney Donors ≥ 65 Years Are Infrequently Utilized Despite Excellent Outcomes

16:30-17:45

21

16:30

Oral Abstract: Kidney Rejection Pathology

Full Details

Karolien Wellekens, Belgium
Intimal Arteritis ('v') in Kidney Transplant Rejection: Multicenter Clinical and Molecular Evidence Challenging the Banff 2022 Classification

Ondrej Viklicky, Czech Republic
Biopsy-Based Transcriptomics of Banff 2022 Antibody-Mediated Rejection Categories

Emmett Wong, Singapore
Microvascular Inflammation Alters the Prognosis Associated with T-Cell-Mediated Rejection

Lukas Weidmann, Switzerland
Molecular Interpretation, Archetype Analysis, and Injury Dimensions Improve Prognostication From Kidney Allograft Biopsies Classified According to Banff 2022

Ilkka Helanterä, Finland
Findings and Significance of Early Follow-Up Biopsies After Treatment of Acute Rejection in Kidney Transplant Recipients

Parmjeet Randhawa, United States
Chronic Active TCMR (ca-TCMR) in the Kidney: Definition, Prevalence, Concurrent Acute TCMR and Banff Activity-Chronicity Indices

Mariko Hunter, United States
Clinical Outcomes Based on Tissue Transcriptomics-Guided Management in Real-World Kidney Transplant Cohort

Valentin Goutaudier, France
Multimodal and Spatial Profiling of Microvascular Inflammation in Kidney Allografts

16:30-17:45

11

16:30

Oral Abstract: Breathing New Life: Improving Outcomes in Lung Transplantation

Full Details

Darren Stewart, United States
Recipient and Donor Factors Associated with BOS/CLAD-Free Graft Survival vs. Graft Survival Alone

Marc Raynaud, France
Trajectories of FEV1 After Lung Transplantation and Patient Outcomes

Justin Wang, United States
Every Minute Matters: The Impact of Donor Agonal Time on Recipient Outcomes in DCD Lung Transplantation

Chelsea Hawkins, United States
Continuous Distribution of Lungs Decreases Waiting List Mortality without Compromising 6-Month Post-Transplant Outcomes

Samantha Weiss, United States
Summary of Trends in Pediatric Transplantation under Lung Continuous Distribution

Kiran Thirukonda, United States
Impact of Ex Vivo Lung Perfusion on Post-Transplant Graft Survival: A Retrospective Analysis of UNOS Data

Dominic Emerson, United States
The Worldwide Robotic Lung Transplantation Experience To-Date: Outcomes in the First Three Centers

Mohamed Elrefaei, United States
Donor HLA-Derived Indirect T Cell Epitope and Surface-Accessible Amino Acid Mismatch Loads Predict Lung Allograft Dysfunction

16:30-17:45

23

16:30

Oral Abstract: Pancreas

Full Details

Farah Abuazzam, United States
Outcomes and Predictors of Pancreas Graft Survival in Simultaneous Pancreas-Kidney Transplant Recipients: A Contemporary Analysis of OPTN Database

Todd Brennan, United States
Comparable Outcomes of Pancreas Transplants from Donation After Circulatory Death Compared to Brain Death Donors

Todd Brennan, United States
Outcomes of Highly Sensitized Pancreas Transplant Recipients in the Modern Era

Dante Puntiel, United States
Challenges in Pancreas Transplantation for Obese Recipients with Type II Diabetes

Todd Brennan, United States
Pancreas Transplantation in Type 2 Diabetics is Associated with Lower Rates of Graft Rejection and Graft Loss Compared with Type 1 Diabetics

Ali Abbasi, United States
A Multicenter Study of Weight Loss and Side Effects in Pancreas Transplant Recipients Treated with GLP-1 Receptor Agonists

Sandesh Parajuli, United States
Positive Malnutrition Risk Factors Pre-Transplant Are Associated with Adverse Outcomes After Simultaneous Kidney and Pancreas and Solitary Pancreas Transplantation

Argyrios Asderakis, United Kingdom
Beta Cell Specific Cell Free DNA and Trypsinogen for the Diagnosis of Rejection in Pancreas Transplantation The EMPAR Study